<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">109327</article-id>
<article-id pub-id-type="doi">10.7554/eLife.109327</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.109327.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
</subj-group>
</article-categories><title-group>
<article-title>PRRT2 as an auxiliary regulator of Nav channel slow inactivation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1456-2517</contrib-id>
<name>
<surname>Lu</surname>
<given-names>Bin</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n3">‡</xref>
<email>lubin@ion.ac.cn</email>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Xu</surname>
<given-names>Qi-Wu</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n3">‡</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n3">‡</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wu</surname>
<given-names>Xue-Mei</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n3">‡</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>He</surname>
<given-names>Jun-Yan</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="author-notes" rid="n3">‡</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Guang</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="author-notes" rid="n1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Ke-Xian</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhuang</surname>
<given-names>Ling</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="author-notes" rid="n2">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yu-Xian</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7727-8412</contrib-id>
<name>
<surname>Xiong</surname>
<given-names>Zhi-Qi</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a5">5</xref>
<xref ref-type="author-notes" rid="n4">§</xref>
<email>xiongzhiqi@ion.ac.cn</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/034t30j35</institution-id><institution>Center for Excellence in Brain Science and Intelligence Technology (Institute of Neuroscience), Chinese Academy of Sciences</institution></institution-wrap>, <city>Shanghai</city>, <country country="CN">China</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/030bhh786</institution-id><institution>School of Life Science and Technology, ShanghaiTech University</institution></institution-wrap>, <city>Shanghai</city>, <country country="CN">China</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05qbk4x57</institution-id><institution>University of Chinese Academy of Sciences</institution></institution-wrap>, <city>Beijing</city>, <country country="CN">China</country></aff>
<aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013q1eq08</institution-id><institution>Department of Neurology, Zhongshan Hospital, Fudan University</institution></institution-wrap>, <city>Shanghai</city>, <country country="CN">China</country></aff>
<aff id="a5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0551a0y31</institution-id><institution>Shanghai Center for Brain Science and Brain-Inspired Intelligence Technology</institution></institution-wrap>, <city>Shanghai</city>, <country country="CN">China</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Griffith</surname>
<given-names>Theanne N</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/05rrcem69</institution-id>
<institution>University of California, Davis</institution>
</institution-wrap>
<city>Davis</city>
<country country="US">United States</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Swartz</surname>
<given-names>Kenton J</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01s5ya894</institution-id>
<institution>National Institute of Neurological Disorders and Stroke</institution>
</institution-wrap>
<city>Bethesda</city>
<country country="US">United States</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn id="n1" fn-type="present-address"><label>*</label><p>Present address: Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China</p></fn>
<fn id="n2" fn-type="present-address"><label>†</label><p>Present address: Hainan Academy of Medical Sciences, Hainan Medical University, Hainan, China</p></fn>
<fn id="n3" fn-type="equal"><label>‡</label><p>These authors contributed equally</p></fn>
<fn id="n4"><label>§</label><p>Lead contact</p></fn>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-12-18">
<day>18</day>
<month>12</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP109327</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-09-26">
<day>26</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-09-28">
<day>28</day>
<month>09</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2025.09.27.678785"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Lu et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Lu et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-109327-v1.pdf"/>
<abstract><p>During sustained activity, voltage-gated sodium (Nav) channels enter a slow-inactivated state to limit cellular hyperexcitability. Disruption of this regulatory process has been implicated in skeletal, cardiac and neurological disorders. While the kinetics of this process are well characterized, its endogenous modulators remain unclear. Here, we identify Proline-Rich Transmembrane Protein 2 (PRRT2) as a native regulator of Nav channel slow inactivation. We show that PRRT2 facilitates the entry of Nav channels into slow-inactivated state and delays their recovery, a regulatory effect conserved from zebrafish to humans. PRRT2 forms molecular complexes with Nav channels both <italic>in vitro</italic> and <italic>in vivo</italic>. In the mouse cortex, PRRT2 deficiency impairs the slow inactivation of Nav channels in neuronal axons, leading to reduced cortical resilience in response to hyperexcitable challenges. Together, these findings establish PRRT2 as a physiological modulator of Nav channel slow inactivation and reveal a mechanism that supports cortical resilience to pathological perturbations.</p>
</abstract>
<funding-group>
<award-group id="funding-1">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01h0zpd94</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>82271269</award-id>
</award-group>
<award-group id="funding-1a">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01h0zpd94</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>82021001</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>
<institution-wrap>
<institution>Innovation of Science and Technology 2030-Major Project “platform of nonhuman primate models”</institution>
</institution-wrap>
</funding-source>
<award-id>2021ZD0200900</award-id>
</award-group>
<award-group id="funding-3">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/03kt66j61</institution-id>
<institution>Shanghai Municipal Science and Technology Major Project</institution>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>

</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Voltage-gated sodium (Nav) channels are critical for the initiation and propagation of electrical signals in excitable cells, contributing to cellular excitability in various tissues(<xref ref-type="bibr" rid="c36">Hodgkin &amp; Huxley, 1952</xref>; <xref ref-type="bibr" rid="c66">Ulbricht, 1977</xref>). In mammals, including humans, Nav channels consist of nine = subunit isoforms (Nav1.1-Nav1.9), which are differentially expressed and distributed across different tissues to regulate specific physiological functions(<xref ref-type="bibr" rid="c12">Catterall, Goldin, &amp; Waxman, 2005</xref>). Mutations in Nav channels that lead to either loss- or gain-of-function of these chan-nels are associated with a wide spectrum of diseases, including neurological disorders(<xref ref-type="bibr" rid="c23">Escayg &amp; Goldin, 2010</xref>; <xref ref-type="bibr" rid="c35">Hedrich, Lauxmann, &amp; Lerche, 2019</xref>; <xref ref-type="bibr" rid="c46">Meisler, Hill, &amp; Yu, 2021</xref>), pain syndromes(<xref ref-type="bibr" rid="c20">Dib-Hajj, Geha, &amp; Waxman, 2017</xref>; <xref ref-type="bibr" rid="c75">Waxman, 2013</xref>), muscle illnesses(<xref ref-type="bibr" rid="c10">Cannon, 2018</xref>; <xref ref-type="bibr" rid="c44">Mantegazza, Cestele, &amp; Catterall, 2021</xref>) and cardiac diseases(<xref ref-type="bibr" rid="c55">Remme, 2013</xref>). Consequently, the Nav channels are considered promising therapeutic targets for treating these conditions(<xref ref-type="bibr" rid="c49">Noreng, Li, &amp; Payandeh, 2021</xref>; <xref ref-type="bibr" rid="c77">Wisedchaisri &amp; Gamal El-Din, 2022</xref>).</p>
<p>Voltage-dependent conformational changes enable Nav channels to transition between resting, open and inactivated states(<xref ref-type="bibr" rid="c13">Catterall, Wisedchaisri, &amp; Zheng, 2020</xref>). Eukaryotic Nav channels undergo two major forms of inactivation (fast and slow inactivation), which are distinguished by their kinetics of onset and recovery(<xref ref-type="bibr" rid="c32">Goldin, 2003</xref>). Fast inactivation is triggered within milliseconds by brief depolarization and is rapidly reversed upon hyperpolarization, typically within tens of milliseconds (<xref ref-type="bibr" rid="c2">Armstrong &amp; Bezanilla, 1977</xref>; <xref ref-type="bibr" rid="c7">Bezanilla &amp; Armstrong, 1977</xref>). In contrast, slow inactivation develops during prolonged depolarizations and the slow inactivated channels require substantially longer periods to recover, ranging from hundreds of milliseconds to minutes(<xref ref-type="bibr" rid="c58">Rudy, 1978</xref>). Previous studies have demonstrated that slow inactivation regulates Nav channel availability during sustained or repetitive depolarization, thus modulating the cellular excitability(<xref ref-type="bibr" rid="c32">Goldin, 2003</xref>; <xref ref-type="bibr" rid="c62">Silva, 2014</xref>; <xref ref-type="bibr" rid="c70">Vilin &amp; Ruben, 2001</xref>). Impairment of this regulatory process due to the mutations in Nav channels has been associated with disorders such as periodic paralysis(<xref ref-type="bibr" rid="c33">Hayward, Sandoval, &amp; Cannon, 1999</xref>), cardiac arrhythmias(<xref ref-type="bibr" rid="c57">Richmond, Featherstone, Hartmann, &amp; Ruben, 1998</xref>; <xref ref-type="bibr" rid="c69">Vilin, Makita, George, &amp; Ruben, 1999</xref>) and epilepsy(<xref ref-type="bibr" rid="c29">Ghovanloo et al., 2023</xref>).</p>
<p>Beyond the intrinsic hierarchical gating mechanisms, auxiliary regulators further modulate Nav channel inactivation dynamics(<xref ref-type="bibr" rid="c32">Goldin, 2003</xref>). For example, β subunits of sodium channels (SCN1B) regulate inactivation of Nav channels in the heterologous expression system, although their effects vary across different Nav isoforms and cell types(<xref ref-type="bibr" rid="c34">He &amp; Soderlund, 2014</xref>; <xref ref-type="bibr" rid="c69">Vilin et al., 1999</xref>; <xref ref-type="bibr" rid="c76">Webb, Wu, &amp; Cannon, 2009</xref>). Fibroblast growth factor homologous factors (FHFs) interact with the carboxy terminus of Nav channels(<xref ref-type="bibr" rid="c27">Gade, Marx, &amp; Pitt, 2020</xref>; <xref ref-type="bibr" rid="c30">Goetz et al., 2009</xref>), promoting intermediated or long-term inactivation, with recovery times spanning hundreds of milliseconds(<xref ref-type="bibr" rid="c21">Dover, Solinas, D’Angelo, &amp; Goldfarb, 2010</xref>; <xref ref-type="bibr" rid="c68">Venkatesan, Liu, &amp; Goldfarb, 2014</xref>). Although these auxiliary proteins have been identified as regulators of fast or intermediate inactivation, native modulators that specifically targeting slow inactivation of Nav channels remain largely unknown.</p>
<p>Recent studies on proline-rich transmembrane protein 2 (PRRT2) provide new insights into this issue. The <italic>PRRT2</italic>, a member of the Dispanins B subfamily (DspB)(<xref ref-type="bibr" rid="c59">Sallman Almen, Bringeland, Fredriksson, &amp; Schioth, 2012</xref>), has been identified as a causative gene for paroxysmal kinesigenic dyskinesia disease(<xref ref-type="bibr" rid="c16">W. J. Chen et al., 2011</xref>; <xref ref-type="bibr" rid="c41">Lee et al., 2012</xref>; <xref ref-type="bibr" rid="c73">J. L. Wang et al., 2011</xref>). <italic>In vitro</italic> studies have shown that PRRT2 regulates Nav channel surface expression and delays recovery of these channels from inactivated states induced by brief depolarization(<xref ref-type="bibr" rid="c26">Fruscione et al., 2018</xref>; <xref ref-type="bibr" rid="c42">Lu et al., 2021</xref>; <xref ref-type="bibr" rid="c67">Valente et al., 2023</xref>). However, these studies did not clearly distinguish between the effects of PRRT2 on fast versus slow inactivation, nor did they provide direct <italic>in vivo</italic> evidence for its role in regulating Nav channel inactivation. Our original observations that PRRT2 expression increased the accumulation of inactivated Nav channels during repetitive stimulation(<xref ref-type="bibr" rid="c42">Lu et al., 2021</xref>) suggest that PRRT2 may be a previously unrecognized auxiliary regulator of Nav channel slow inactivation. In this study, we combined whole-cell voltage-clamp recordings, co-immunoprecipitation, and <italic>in vivo</italic> approaches to investigate the role of PRRT2 in regulating Nav channel slow inactivation, and to examine how deficits in PRRT2-mediated modulation of this process affects neuronal function in awake mice.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>PRRT2 regulates the slow inactivation of Nav1.2 channels</title>
<p>Fast and slow inactivation of Nav channels proceed through distinct gating pathways(<xref ref-type="bibr" rid="c32">Goldin, 2003</xref>). Although previous studies have implicated PRRT2 in the regulation of Nav channel inactivation(<xref ref-type="bibr" rid="c26">Fruscione et al., 2018</xref>; <xref ref-type="bibr" rid="c42">Lu et al., 2021</xref>), it remains unclear whether PRRT2 primarily influences fast inactivation, slow inactivation or both. To address this, we express mouse PRRT2 in HEK293T cells stably expressing Nav1.2 (<xref rid="fig1" ref-type="fig">Figure 1A</xref>) and applied classic electrophysiological paradigms to distinguish between the two inactivation processes.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1</label>
<caption>
<title>PRRT2 regulates slow inactivation of Nav1.2 channels.</title>
<p><bold>(A)</bold> Representative immunoblots showing PRRT2 protein expression in Nav1.2-stably expressing HEK293T cells transfected with constructs encoding either EGFP or mouse PRRT2 (mPRRT2). MW, molecular weight. <bold>(B)</bold> Schematic of whole-cell recording (left) and representative traces of sodium currents evoked by a brief depolarization (right). The arrow indicate sodium current decay due to fast inactivation. Scale bar, 1 nA by 2 ms. <bold>(C)</bold> Decay time constants of sodium currents in response to 20-ms depolarization (EGFP: <italic>n</italic> = 13 cells, mPRRT2: <italic>n</italic> = 13 cells). <bold>(D)</bold> Recovery from fast inactivation of Nav1.2 channels (EGFP: <italic>n</italic> = 10 cells, mPRRT2: <italic>n</italic> = 7 cells). Insert: Protocol for examining fast inactivation recovery. <bold>(E)</bold> Schematic diagram of entry into and recover from slow inactivation of voltage-gated sodium channels. Slow inactivation modulates the availability of the sodium channels. <bold>(F)</bold> Entry into slow-inactivated state of Nav1.2 channels induced by progressive longer depolarization (EGFP: <italic>n</italic> = 6 cells, mPRRT2: <italic>n</italic> = 6 cells). <bold>(G)</bold> The effects of PRRT2 on the recovery of Nav1.2 channels from slow-inactivated state induced by 5-s depolarization (EGFP: <italic>n</italic> = 6 cells, PRRT2: <italic>n</italic> = 6 cells). Data were presented as mean ± s.e.m. Two-tailed, unpaired Student’s <italic>t</italic>-test was used in C, and two-way ANOVAs were used in D, F, and G. ****<italic>P</italic> &lt; 0.0001. n.s.,not significant.</p>
</caption>
<graphic xlink:href="678785v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig1-s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1-figure supplement 1.</label>
<caption>
<title>PRRT2 promotes steady-state slow inactivation.</title>
<p><bold>(A)</bold>Protocol of steady-state slow inactivation test (left) and representative traces of the sodium currents evoked by test pulses (right). The sodium currents gradually decreased as the voltage in conditioning steps increased. Scale bar, 0.5 nA by 2 ms. <bold>(B and C)</bold> The effects of PRRT2 on voltage-dependent steady-state slow inactivation of Nav1.2 channels (B) (EGFP: <italic>n</italic> = 11 cells, mPRRT2: <italic>n</italic> = 13 cells). mPRRT2, mouse PRRT2. Data were presented as mean ± s.e.m. Two-way ANOVAs were used in (B) to determine the statistical significance of main effects of group. ****<italic>P</italic> &lt; 0.0001.</p>
</caption>
<graphic xlink:href="678785v1_fig1-s1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Fast inactivation of Nav channels is rapidly triggered by brief depolarization and manifests as a current decay following a transient pore opening (<xref rid="fig1" ref-type="fig">Figure 1B</xref>), consistent with previous reports(<xref ref-type="bibr" rid="c47">Misra, Kahlig, &amp; George, 2008</xref>; <xref ref-type="bibr" rid="c64">Thompson et al., 2023</xref>). To evaluate the kinetics of fast inactivation, we measured the time constant of current decay and found that PRRT2 expression did not significantly alter the rate at which Nav channels entered the fast-inactivated state (<xref rid="fig1" ref-type="fig">Figure 1C</xref>). Moreover, the majority of Nav1.2 channels recovered from fast inactivation within ∼10 ms at a hyperpolarized potential of −120 mV, and PRRT2 expression had a minimal effect on this recovery (<xref rid="fig1" ref-type="fig">Figure 1D</xref>).</p>
<p>In contrast to fast inactivation, Nav channel slow inactivation develops and recovers over much longer timescales (<xref rid="fig1" ref-type="fig">Figure 1E</xref>), typically ranging from hundreds of milliseconds to seconds, or even to minutes(<xref ref-type="bibr" rid="c62">Silva, 2014</xref>). Because slow-inactivated channels do not recover during brief hyperpolarization, they can be functionally distinguished from fast-inactivated channels using a classic two-pulse protocol. In this approach, a brief hyperpolarization step (e.g., −120 mV, 10 ms) is inserted between a conditioning pulse and a test pulse to recover fastinactivated channels. Channels that have entered the slow-inactivated state remain unavailable during the test pulse, resulting in a reduction in peak sodium current (<xref rid="fig1" ref-type="fig">Figure 1E</xref>)(<xref ref-type="bibr" rid="c24">Featherstone, Richmond, &amp; Ruben, 1996</xref>).</p>
<p>To assess the development of slow inactivation, we applied depolarization pulses of variable duration, followed by a fixed 10-ms hyperpolarization before the test pulse (<xref rid="fig1" ref-type="fig">Figure 1F</xref>). We found that a 5-second depolarization at 0 mV was sufficient to drive most Nav1.2 channels into the slow-inactivated state (<xref rid="fig1" ref-type="fig">Figure 1F</xref>), consistent with previous studies(<xref ref-type="bibr" rid="c28">Ganguly, Thompson, &amp; George, 2021</xref>). PRRT2 significantly promoted the entry of Nav1.2 channels into the slow-inactivated state during sustained depolarization (<xref rid="fig1" ref-type="fig">Figure 1F</xref>).</p>
<p>To examine the role of PRRT2 in channel recovery from slow inactivation, we used a protocol in which a fixed 5-second depolarization at 0 mV was followed by varying durations of hyperpolarization at −120 mV to allow channel repriming (<xref rid="fig1" ref-type="fig">Figure 1G</xref>). PRRT2 expression markedly slowed the recovery of Nav channels from the slow-inactivated state (<xref rid="fig1" ref-type="fig">Figure 1G</xref>).</p>
<p>To further investigate whether the regulation of PRRT2 in slow inactivation is voltage dependent, we performed a steady-state slow inactivation protocol. In this assay, 10-s depolarizing steps from −110 to −10 mV were applied to drive Nav channels into steady state, followed by a fixed hyperpolarization and a test pulse to assess channel availability (<xref rid="fig1-s1" ref-type="fig">Figure 1-figure supplement 1A</xref>). We found that PRRT2 promotes the transition of Nav channels into the slowinactivated state across a broad range of membrane potentials. PRRT2 expression induced a pronounced hyperpolarizing shift in the inactivation curve, with a V<sub>0.5</sub> of −76.27 mV compared to −48.05 mV in controls (<xref rid="fig1-s1" ref-type="fig">Figure 1-figure supplement 1B</xref>). Together, these findings indicate that PRRT2 is a potent regulator of Nav1.2 channel slow inactivation <italic>in vitro</italic>.</p>
</sec>
<sec id="s2b">
<title>Functional auxiliary factors in the regulation of Nav channel slow inactivation</title>
<p>Several auxiliary factors of Nav channels have been identified, including the SCN1B and FHF2A (also known as FGF13a), both of which are implicated in modulating Nav channel inactivation(<xref ref-type="bibr" rid="c21">Dover et al., 2010</xref>; <xref ref-type="bibr" rid="c39">Isom et al., 1992</xref>). In this study, we compared the effects of mouse SCN1B and FGF13a with those of PRRT2 on the development and recovery of Nav channel slow inactivation (<xref rid="fig2" ref-type="fig">Figure 2A</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2</label>
<caption>
<title>Functional auxiliary factors in the regulation of Nav channel slow inactivation.</title>
<p><bold>(A)</bold> Diagram of Nav channel with potent auxiliary factors, encompassing SCN1B, FHF2A (also known as FGF13a) and PRRT2. <bold>(B)</bold> The effects of auxiliary factors on the entry of Nav1.2 channels into slow inactivation (EGFP: <italic>n</italic> = 12 cells, mPRRT2: <italic>n</italic> = 14 cells, SCN1B: <italic>n</italic> = 9 cells, FGF13a: <italic>n</italic> = 12 cells). <bold>(C)</bold> The effects of auxiliary factors on the recovery of Nav1.2 channels from slow-inactivated state induced by 5-s depolarization (EGFP: <italic>n</italic> = 12 cells, mPRRT2: <italic>n</italic> = 12 cells, SCN1B: <italic>n</italic> = 12 cells, FGF13a: <italic>n</italic> = 12 cells). <bold>(D)</bold> Schematic representation of the putative topology of mouse PRRT2 and three truncates. Numbers indicate the positions of the amino acid. REL, re-entrant loop. TM, transmembrane domain. N, amino terminus. C, carboxyl terminus. aa, amino acid. <bold>(E)</bold> The effects of PRRT2 truncates on the entry of Nav1.2 channels into slow inactivation (EGFP: <italic>n</italic> = 5 cells, mPRRT2(1–266): <italic>n</italic> = 14 cells, mPRRT2(222–346): <italic>n</italic> = 12 cells, mPRRT2(256–346): <italic>n</italic> = 12 cells). <bold>(F)</bold> The effects of PRRT2 truncates on the recovery of Nav1.2 channels from slow-inactivated state induced by 5-s depolarization (EGFP: <italic>n</italic> = 5 cells, mPRRT2(1–266): <italic>n</italic> = 10 cells, mPRRT2(222–346): <italic>n</italic> = 10 cells, mPRRT2(256–346): <italic>n</italic> = 12 cells). Data were presented as mean ± s.e.m. The main effect of group was assessed using two-way ANOVAs (B, C, E and F). **<italic>P</italic> &lt; 0.01, ****<italic>P</italic> &lt; 0.0001, n.s., not significant.</p>
</caption>
<graphic xlink:href="678785v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We found that SCN1B had negligible effects on both the entry into and recovery from the slow-inactivated state of Nav1.2 compared to controls (<xref rid="fig2" ref-type="fig">Figures 2B</xref> and <xref rid="fig2" ref-type="fig">C</xref>). In contrast, FGF13a markedly accelerated the onset of inactivation (<xref rid="fig2" ref-type="fig">Figure 2B</xref>), consistent with previous reports(<xref ref-type="bibr" rid="c21">Dover et al., 2010</xref>; <xref ref-type="bibr" rid="c68">Venkatesan et al., 2014</xref>). Notably, FGF13a had minimal effect on the recovery of Nav channels from the slow-inactivated state induced by a 5-second depolarization (<xref rid="fig2" ref-type="fig">Figure 2C</xref>). These distinct effects of FGF13a on inactivation suggest that FGF13a does not modulate classical slow inactivation, but rather promotes a form of rapid-onset and long-term inactivation(<xref ref-type="bibr" rid="c21">Dover et al., 2010</xref>; <xref ref-type="bibr" rid="c68">Venkatesan et al., 2014</xref>). By comparison, PRRT2 uniquely regulated slow inactivation by both facilitating entry into and delaying recovery from the slow-inactivated state of Nav channels (<xref rid="fig2" ref-type="fig">Figures 2B</xref> and <xref rid="fig2" ref-type="fig">C</xref>).</p>
<p>The rodent <italic>Prrt2</italic> gene encodes a 346-amino-acid protein containing a proline-rich domain in the N-terminus, a re-entrant loop, and a transmembrane domain in the C-terminus (<xref rid="fig2" ref-type="fig">Figure 2D</xref>). To identify the functional domain(s) responsible for regulating slow inactivation, we generated a series of protein-truncating variants (<xref rid="fig2" ref-type="fig">Figure 2D</xref>).</p>
<p>We first examined PRRT2(222–346), which lacks the N-terminal proline-rich domain (<xref rid="fig2" ref-type="fig">Figure 2D</xref>). This variant retained activity similar to the full-length PRRT2, enhancing slow inactivation development and delaying recovery (<xref rid="fig2" ref-type="fig">Figures 2E</xref> and <xref rid="fig2" ref-type="fig">F</xref>). A shorter construct, PRRT2(256– 346), which retains the intact C-terminus, also preserved regulatory function in modulating slow inactivation compared to the EGFP control (<xref rid="fig2" ref-type="fig">Figures 2E</xref> and <xref rid="fig2" ref-type="fig">F</xref>). To further test whether the C-terminal region is necessary for the effect of PRRT2 on Nav channel slow inactivation, we examined PRRT2(1–266), a truncated variant lacking the membrane-associated C-terminal domains (<xref rid="fig2" ref-type="fig">Figure 2D</xref>). Unlike variants containing the C-terminal region, PRRT2(1–266) showed no detectable effect on either the development or recovery of Nav channel slow inactivation compared to the control (<xref rid="fig2" ref-type="fig">Figures 2E</xref> and <xref rid="fig2" ref-type="fig">F</xref>).</p>
<p>Together, these results indicate that the C-terminal region of PRRT2, including the re-entrant loop and transmembrane domain, is both necessary and sufficient to mediate its regulatory effect on slow inactivation of Nav1.2 channels <italic>in vitro</italic>.</p>
</sec>
<sec id="s2c">
<title>Evolutionarily conserved effects of PRRT2 on Nav channel slow inactivation</title>
<p>The <italic>PRRT2</italic> and <italic>PRRT2</italic>-like genes emerged in vertebrates and have been conserved throughout evolution(<xref ref-type="bibr" rid="c59">Sallman Almen et al., 2012</xref>). The alignment of amino acid sequences from zebrafish, mouse, and human PRRT2 revealed 77.46% identity between human and mouse PRRT2, and 43.60% identity between zebrafish and mouse PRRT2 (<xref rid="fig3" ref-type="fig">Figures 3A</xref> and <xref rid="fig3" ref-type="fig">3B</xref>). Notably, the majority of conserved residues are located within the C-terminal region of the PRRT2 proteins (<xref rid="fig3" ref-type="fig">Figure 3A</xref>). Given the essential role of the C-terminus of mouse PRRT2 in regulating Nav channel slow inactivation, we examined whether PRRT2 proteins from different species exhibit similar effects.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3</label>
<caption>
<title>Evolutionarily conserved effects of PRRT2 on Nav channel slow inactivation.</title>
<p><bold>(A)</bold> Sequence alignment of PRRT2 protein in human, mouse and zebrafish. Conserved amino acids are highlighted and the membrane-associated domains in carboxyl terminus of PRRT2 are underlined. REL, re-entrant loop. TM, transmembrane domain. <bold>(B)</bold> Sequence identity of PRRT2 protein in human (hPRRT2), mouse (mPRRT2) and zebrafish (zfPRRT2). Identity is calculated by using protein BLAST tool from NCBI. <bold>(C)</bold> The effects of PRRT2 from different species on the entry of Nav1.2 channels into slow inactivation (EGFP: <italic>n</italic> = 16 cells, mPRRT2: <italic>n</italic> = 19 cells, hPRRT2: <italic>n</italic> = 20 cells, zfPRRT2: <italic>n</italic> = 11 cells). <bold>(D)</bold> The effects of PRRT2 from different species on the recovery of Nav1.2 channels from slow-inactivated state induced by 5-s depolarization (EGFP: <italic>n</italic> = 16 cells, mPRRT2: <italic>n</italic> = 19 cells, hPRRT2: <italic>n</italic> = 19 cells, zfPRRT2: <italic>n</italic> = 11 cells). <bold>(E)</bold> Diagram for the chimeric construct of PRRT2 originated from human and zebrafish. <bold>(F)</bold> The effect of chimeric PRRT2 on the entry of Nav1.2 channels into slow inactivation (EGFP: <italic>n</italic> = 11 cells, hPRRT2: <italic>n</italic> = 6 cells, zfPRRT2: <italic>n</italic> = 10 cells, Chimera: <italic>n</italic> = 11 cells). <bold>(G)</bold> The effect of Chimeric PRRT2 on the recovery of Nav1.2 channels from slow-inactivated state induced by 5-s depolarization (EGFP: <italic>n</italic> = 11 cells, hPRRT2: <italic>n</italic> = 6 cells, zfPRRT2: <italic>n</italic> = 10 cells, Chimera: <italic>n</italic> = 9 cells). Data were presented as mean ± s.e.m. The main effect of group was assessed using two-way ANOVAs (C, D, F and G). **<italic>P</italic> &lt; 0.01, ****<italic>P</italic> &lt; 0.0001, n.s., not significant.</p>
</caption>
<graphic xlink:href="678785v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig3-s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3-figure supplement 1.</label>
<caption>
<title>Paralogs of PRRT2 regulate Nav channel slow inactivation.</title>
<p><bold>(A)</bold> Sequence alignment of mouse TRARG1, TMEM233 and PRRT2 proteins. Conserved amino acids are highlighted and the transmembrane domains in carboxyl terminus of these proteins are underlined. REL, re-entrant loop. TM, transmembrane domain. <bold>(B)</bold> Schematic showing the phylogenetic relationship between members of Dispanin subfamily B (DspB). <bold>(C)</bold> The effects of members of DspB on the entry of Nav1.2 channels into slow inactivation (EGFP: <italic>n</italic> = 13 cells, TRARG1: <italic>n</italic> = 17 cells, TMEM233: <italic>n</italic> = 13 cells, PRRT2: <italic>n</italic> = 13 cells). <bold>(D)</bold> The effects of members of DspB on the recovery of Nav1.2 channels from slowinactivated states induced by 5-s depolarization (EGFP: <italic>n</italic> = 10 cells, TRARG1: <italic>n</italic> = 14 cells, TMEM233: <italic>n</italic> = 12 cells, PRRT2: <italic>n</italic> = 12 cells). Data were presented as mean ± s.e.m. The main effect of group was assessed using two-way ANOVAs (C and D). **<italic>P</italic> &lt; 0.01, ****<italic>P</italic> &lt; 0.0001, n.s., not significant.</p>
</caption>
<graphic xlink:href="678785v1_fig3-s2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>By comparing the effects of zebrafish, mouse, and human PRRT2 on Nav channel slow inactivation, we found that all three PRRT2 orthologs similarly promoted the entry of Nav1.2 channels into the slow-inactivated state (<xref rid="fig3" ref-type="fig">Figure 3C</xref>). Surprisingly, in recovery assays, zebraf-ish PRRT2 was more effective at delaying the recovery process compared to its mammalian counterparts (<xref rid="fig3" ref-type="fig">Figure 3D</xref>). To identify the determinant domain of zebrafish PRRT2 for this enhanced effect, we generated a chimeric PRRT2 construct by fusing the C-terminal region of zebrafish PRRT2 to the N-terminal region of human PRRT2 (<xref rid="fig3" ref-type="fig">Figure 3E</xref>). The chimeric PRRT2 exhibited comparable effects on the rate of slow inactivation development to those observed with both human and zebrafish PRRT2 (<xref rid="fig3" ref-type="fig">Figure 3F</xref>). Notably, the chimeric variant displayed enhanced modulation of recovery, resembling zebrafish PRRT2 and significantly differing from human PRRT2 (<xref rid="fig3" ref-type="fig">Figure 3G</xref>). These findings indicate that C-terminal region of zebrafish PRRT2 confers its greater ability to modulate recovery of Nav1.2 from slow-inactivated state. We next extended our analysis to other DspB family members, including <italic>Trafficking regulator of GLUT4-1</italic> (<italic>trarg1</italic>) and <italic>Transmembrane protein 233</italic> (<italic>tmem233</italic>), both of which encode proteins with C-terminal regions similar to that of PRRT2 (Figure 3-figure supplement 3A and B). Given the critical role of the PRRT2 C-terminus in modulating slow inactivation, we hypothesized that TRARG1 and TMEM233 might exert similar regulatory effects. Under heterologous expression conditions, both TRARG1 and TMEM233 facilitated the entry of Nav1.2 channels into the slow-inactivated state and delayed their recovery (Figure 3-figure supplement 3C and D). These effects were comparable to those observed with mouse PRRT2, although TMEM233 exhibited slightly weaker modulation than PRRT2 and TRARG1 (Figure 3-figure supplement 3C and D).</p>
<p>Together, these results suggest that the role of PRRT2 in regulating Nav channel slow inactivation is evolutionarily conserved.</p>
</sec>
<sec id="s2d">
<title>Uniform influence of PRRT2 on slow inactivation across human Nav isoforms</title>
<p>In humans, the nine Nav channel isoforms (Nav1.1-1.9) share high sequence homology and similar structural features(<xref ref-type="bibr" rid="c31">Goldin, 2001</xref>). To investigate whether PRRT2 modulates slow inactivation across different Nav channel isoforms, we selected Nav1.1, Nav1.4, and Nav1.5, which are expressed in distinct tissues, and assessed the effects of human PRRT2 on their slow inactivation properties (<xref rid="fig4" ref-type="fig">Figures 4A-H</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4</label>
<caption>
<title>Uniform influence of PRRT2 on slow inactivation across human Nav isoforms.</title>
<p><bold>(A)</bold> Protocol for examining the entry of Nav channels into slow-inactivated state. <bold>(B-D)</bold> The effects of human PRRT2 (hPRRT2) on the entry of Nav1.1, Nav1.4 and Nav1.5 channels into slow inactivation. In (B), analyses for Nav1.1 (EGFP: <italic>n</italic> = 10 cells, hPRRT2: <italic>n</italic> = 12 cells); In (C), analyses for Nav1.4 (EGFP: <italic>n</italic> = 11 cells, hPRRT2: <italic>n</italic> = 11 cells); In (D), analyses for Nav1.5 (EGFP: <italic>n</italic> = 17 cells, hPRRT2: <italic>n</italic> = 17 cells). <bold>(E)</bold> Protocol for examining the recovery of Nav channels from slow-inactivated state. <bold>(F</bold>-<bold>H)</bold> The effects of human PRRT2 on the recovery of Nav1.1, Nav1.4 and Nav1.5 channels from slow-inactivated state induced by 5-s depolarization. In (F), analyses for Nav1.1 (EGFP: <italic>n</italic> = 10 cells, hPRRT2: <italic>n</italic> = 12 cells); In (G), analyses for Nav1.4 (EGFP: <italic>n</italic> = 11 cells, hPRRT2: <italic>n</italic> = 11 cells); In (H), analyses for Nav1.5 (EGFP: <italic>n</italic> = 16 cells, hPRRT2: <italic>n</italic> = 15 cells). Data were presented as mean ± s.e.m. The main effect of group was assessed using two-way ANOVAs (B-D and F-H). ****<italic>P</italic> &lt; 0.0001.</p>
</caption>
<graphic xlink:href="678785v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig4-s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4-figure supplement 1.</label>
<caption>
<title>Absence of effect of PRRT2 on Kv1.4 channel inactivation.</title>
<p><bold>(A)</bold> Illustration showing the whole-cell voltage-clamp recording in Kv1.4 stably expressing HEK293T cells (upper) and representative traces of potassium currents evoked by a depolarization at 40 mV (bottom). Scale bar, 1 nA by 50 ms. <bold>(B)</bold> The effects of human PRRT2 on the entry of Kv1.4 channels into inactivated state (EGFP: <italic>n</italic> = 9 cells, hPRRT2: <italic>n</italic> = 8 cells). <bold>(C)</bold> The effects of human PRRT2 on the recovery of Kv1.4 channels from inactivated states induced by 5-s depolarization (EGFP: <italic>n</italic> = 8 cells; hPRRT2: <italic>n</italic> = 7 cells). Data were presented as mean ± s.e.m. The main effect of group was assessed using two-way ANOVAs (B and C). n.s., not significant.</p>
</caption>
<graphic xlink:href="678785v1_fig4-s3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Both Nav1.1 and Nav1.4 exhibited similar kinetics in the development and recovery of slow inactivation (<xref rid="fig4" ref-type="fig">Figures 4B, C, F</xref> and <xref rid="fig4" ref-type="fig">G</xref>). In contrast, Nav1.5 showed greater resistance to entering the slow-inactivated state (<xref rid="fig4" ref-type="fig">Figures 4D</xref> and <xref rid="fig4" ref-type="fig">H</xref>), consistent with previous findings(<xref ref-type="bibr" rid="c57">Richmond et al., 1998</xref>). Despite these isoform-specific differences, the heterologous expression of PRRT2 consistently promoted entry of Nav channels into the slow-inactivated state (<xref rid="fig4" ref-type="fig">Fig. 4A-D</xref>) and delayed recovery from it (<xref rid="fig4" ref-type="fig">Figures 4E-H</xref>) across all three Nav isoforms tested. These results suggest that PRRT2 modulates slow inactivation through a common mechanism shared by multiple isoforms of Nav channels.</p>
<p>To assess whether the regulatory effect of PRRT2 on slow inactivation is specific to Nav channels, we further examined its influence on the A-type voltage-dependent potassium channel, Kv1.4 (Figure 4-figure supplement 4A). Kv1.4 exhibits two types of inactivation: N-type and C-type, which are functionally analogous to the fast and slow inactivation observed in mammalian Nav channels(<xref ref-type="bibr" rid="c37">Hoshi, Zagotta, &amp; Aldrich, 1990</xref>). Unlike Nav channels, where fast and slow inactivation can be temporally separated, C-type inactivation in Kv1.4 cannot be clearly isolated from N-type inactivation due to the relatively slow recovery kinetics of the latter(<xref ref-type="bibr" rid="c6">Bett, Dinga-Madou, Zhou, Bondarenko, &amp; Rasmusson, 2011</xref>). Given this limitation, we employed a modified assay that did not distinguish between N- and C-type inactivation. Using this protocol, we found that PRRT2 has negligible effects on both the entry into and recovery from the inactivated state of Kv1.4 (Figure 4-figure supplement 4B and C). Since recovery from inactivation in Kv1.4 is primarily governed by C-type inactivation(<xref ref-type="bibr" rid="c6">Bett et al., 2011</xref>), this lack of effect suggests that PRRT2 does not modulate slow inactivation in Kv1.4.</p>
<p>Together, these findings indicate that PRRT2 selectively regulates slow inactivation in Nav channels but does not influence inactivation in Kv1.4, supporting the channel-type specificity of PRRT2 function.</p>
</sec>
<sec id="s2e">
<title>Intermolecular interaction between PRRT2 and Nav channels <italic>in vitro</italic></title>
<p>PRRT2 may regulate slow inactivation by interacting with Nav channels. To examine the potential physical association between human PRRT2 and Nav1.2, we co-expressed PRRT2-HA and Flag-Nav1.2 in HEK293T cells and performed co-immunoprecipitation (co-IP) assays (<xref rid="fig5" ref-type="fig">Figures 5A</xref> and <xref rid="fig5" ref-type="fig">B</xref>). As controls, cells were transfected with one of the two interacting proteins (either PRRT2-HA or Flag-Nav1.2) together with the empty vectors carrying the corresponding tag of the other protein (<xref rid="fig5" ref-type="fig">Figures 5A</xref> and <xref rid="fig5" ref-type="fig">B</xref>). Immunoprecipitation using an anti-Flag antibody to capture Flag-Nav1.2 successfully co-precipitated PRRT2 in the co-transfection group, but not in the control groups where either protein was expressed (<xref rid="fig5" ref-type="fig">Figure 5A</xref>). Conversely, immunoprecipitation with anti-HA antibody showed that Nav1.2 was specifically co-precipitated with PRRT2-HA in the co-transfection group but not in controls (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). These results confirm that PRRT2 and Nav1.2 formed a protein complex <italic>in vitro</italic>.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5</label>
<caption>
<title>Intermolecular interaction between PRRT2 and Nav channels <italic>in vitro</italic>.</title>
<p><bold>(A and B)</bold> Schematic diagram showing the co-immunoprecipitation for detecting human PRRT2-Nav1.2 interaction. Flag-tagged Nav1.2 (+), HA-tagged PRRT2 (+) and empty (−) vectors were transfected in HEK293T cells as indicated. The cell lysates were immunoprecipitated with anti-Flag (A) or anti-HA (B) magnetic beads, the captured proteins were analyzed by SDS-PAGE and immunoblotting. <bold>(C)</bold> Diagram for HA-tagged truncation of human PRRT2 (PRRT2(1–268)), in which the carboxyl terminus of PRRT2 was deleted. REL, re-entrant loop. TM, transmembrane domain. <bold>(D and E)</bold> Co-immunoprecipitation assay for potential interaction between Nav1.2 and PRRT2(1–268). The proteins immunoprecipitated by anti-Flag (D) or anti-HA (E) magnetic beads were analyzed by immunoblotting. Note that HA-tagged PRRT2(1–268) was detected by anti-HA antibody in (D and E). <bold>(F)</bold> Diagram for HA-tagged truncation of human PRRT2 (PRRT2(250–340)), in which the amino terminus of PRRT2 was deleted. <bold>(G and H)</bold> Co-immunoprecipitation assay for potent interaction between Nav1.2 and PRRT2(250–340). The proteins immunoprecipitated by anti-Flag (G) or anti-HA (H) were analyzed by immunoblotting. Note that HA-tagged PRRT2(250–340) was detected by anti-HA antibody in (G and H). <bold>(I and J)</bold> Co-immunoprecipitation assay for potential interaction between Nav1.1 and PRRT2. The proteins captured by anti-Flag (I) or anti-HA (J) magnetic beads were analyzed by immunoblotting. In (A, B, D, E, G, H, I and J), blots shown are representative of at least three independent co-immunoprecipitation experiments with similar results. Red rectangles indicate the immunoblotting of bait and potential prey proteins in co-immunoprecipitation. IB, immunoblot. IP, immunoprecipitation. MW, molecular weight.</p>
</caption>
<graphic xlink:href="678785v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To identify the Nav1.2-binding domain within human PRRT2, we generated truncated constructs encoding either the N-terminus (residues 1–268 amino acid) or C-terminus (residues 250–340 amino acid) of PRRT2. Using the same co-IP approach, we found that PRRT2(1– 268), which contains the intracellular proline-rich domain, failed to interact with Nav1.2 (<xref rid="fig5" ref-type="fig">Figures 5C-E</xref>). In contrast, the PRRT2(250–340), which includes the re-entry loop and transmembrane domain, was able to bind Nav1.2 (<xref rid="fig5" ref-type="fig">Figures 5F-H</xref>). These results demonstrate that C-terminal region of PRRT2 is both necessary and sufficient for interacting with Nav1.2 channels.</p>
<p>Given that PRRT2 modulates slow inactivation across multiple Nav isoforms, we hypothesized that it could interact with other Nav isoforms, such as Nav1.1. To test this, we coexpressed PRRT2-HA and Flag-Nav1.1 in HEK293T cells and performed co-IP assays. Under these conditions, PRRT2 was found to interact with Nav1.1 (<xref rid="fig5" ref-type="fig">Figures 5I</xref> and <xref rid="fig5" ref-type="fig">J</xref>), similar to the interaction observed with Nav1.2 (<xref rid="fig5" ref-type="fig">Figures 5A</xref> and <xref rid="fig5" ref-type="fig">B</xref>).</p>
<p>These findings contrast with previous reports, which reported that PRRT2 preferentially interacted with Nav1.2 over Nav1.1 <italic>in vitro</italic>(<xref ref-type="bibr" rid="c25">Franchi et al., 2023</xref>; <xref ref-type="bibr" rid="c26">Fruscione et al., 2018</xref>; <xref ref-type="bibr" rid="c67">Valente et al., 2023</xref>). This discrepancy may stem from differences in the experimental conditions used to assess protein-protein interactions. For example, in our study, Nav1.1 and PRRT2 were co-expressed in HEK293T cells, and cells were solubilized using the detergent n-Dodecyl β-D-maltoside (DDM). Variations in experimental conditions could influence the stability of PRRT2-Nav channel complex and the efficiency of Co-IP assay.</p>
<p>Collectively, our findings suggest that PRRT2 interacts directly with Nav channels through its membrane-associated C-terminal domains, forming molecular complexes <italic>in vitro</italic>.</p>
</sec>
<sec id="s2f">
<title>PRRT2 forms a molecular complex with Nav1.2 in the mouse brain</title>
<p>To extend our findings from the heterologous expression system to an <italic>in vivo</italic> context, we first investigated whether PRRT2 forms a protein complex with Nav channels in brain tissue. Due to the limited efficacy of available antibodies for immunoprecipitating native PRRT2 or Nav1.2 from brain lysates, we employed a tag-based capture strategy, which relies on the appropriate insertion of a commonly used epitope tag into the target protein.</p>
<p>We generated <italic>Prrt2-V5</italic> knock-in mice via CRISPR/Cas9 technology(<xref ref-type="bibr" rid="c81">Yang, Wang, &amp; Jaenisch, 2014</xref>), in which a V5 epitope tag was inserted at the C-terminus of PRRT2 (<xref rid="fig6" ref-type="fig">Figures 6A</xref> and <xref rid="fig6" ref-type="fig">B</xref>). Notably, compared to wild-type mice, PRRT2 protein levels in lysates were markedly reduced in <italic>Prrt2-V5</italic> knock-in mice, likely due to the insertion of V5 tag, whereas Nav1.2 expression remained unchanged (<xref rid="fig6" ref-type="fig">Figures 6C-E</xref>). Despite the reduced PRRT2 expression, coimmunoprecipitation assays were effective. Using anti-V5 nanobody-conjugated magnetic beads, PRRT2 was effectively immunoprecipitated from membrane lysates of brain tissue (<xref rid="fig6" ref-type="fig">Figure 6C</xref>). A notable amount of Nav1.2 were co-immunoprecipitated in the <italic>Prrt2-V5</italic> knockin group, whereas only trace levels were detected in wild-type controls (<xref rid="fig6" ref-type="fig">Figures 6C</xref> and <xref rid="fig6" ref-type="fig">F</xref>). In contrast, ATP1B2, another membrane protein, was not co-immunoprecipitated in the <italic>Prrt2-V5</italic> group (<xref rid="fig6" ref-type="fig">Figures 6C</xref> and <xref rid="fig6" ref-type="fig">F</xref>), indicating that the interaction between PRRT2 and Nav1.2 is specific. Together, these results provide <italic>in vivo</italic> evidence that PRRT2 forms a molecular complex with Nav1.2 channels in the mouse brain.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6</label>
<caption>
<title>PRRT2 forms a molecular complex with Nav1.2 in the mouse brain.</title>
<p><bold>(A)</bold> Schematic showing the generation of <italic>Prrt2</italic>-<italic>V5</italic> knock-in (V5-KI) mice using Cas9 technology. V5-tag sequence was inserted precisely at the end of <italic>Prrt2</italic> gene. PAM, protospaceradjacent motif (NGG). ssDNA, single-strand DNA. <bold>(B)</bold> Sanger sequencing around sgRNA targeting site in <italic>Prrt2</italic>-<italic>V5</italic> knock-in mouse. The V5-tag, stop codon and homologous arms were denoted. <bold>(C)</bold> Co-immunoprecipitation assay for potential interaction between Nav1.2 and PRRT2-V5 in the brain tissue. The proteins immunoprecipitated by anti-V5 nanobody were analyzed by immunoblotting. Blots shown are representative of four independent co-immunoprecipitation experiments. IB, immunoblot. IP, immunoprecipitation. MW, molecular weight. WT, wild-type. KI, knock-in. <bold>(D-F)</bold> Quantification of the density of protein bands for PRRT2 (D) and Nav1.2 (E) in lysate, and for Nav1.2 and ATP1B2 in Co-immunoprecipitation experiments (F) (<italic>n</italic> = 4 mice for each group). Data were presented as mean ± s.e.m. In (D-F), two-tailed, paired Student’s <italic>t</italic>-test was used for determining statistical significance. **<italic>P</italic> &lt; 0.01, ****<italic>P</italic> &lt; 0.0001, n.s., not significant.</p>
</caption>
<graphic xlink:href="678785v1_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2g">
<title>PRRT2 deficiency impairs the regulation of Nav channel slow inactivation in cortical neuronal axons</title>
<p>Given the dense distribution of both PRRT2 and Nav channels in the cerebral and cerebellar cortices(<xref ref-type="bibr" rid="c80">Yamano, Miyazaki, &amp; Nukina, 2022</xref>), we next investigated whether PRRT2 regulates Nav channel slow inactivation in cortical neurons. Cortical slices were prepared from wild-type and <italic>Prrt2</italic>-mutant mice, the latter lacking PRRT2 expression(<xref ref-type="bibr" rid="c63">Tan et al., 2018</xref>). Unlike the relatively simple morphology of HEK293T cells, pyramidal neurons have complex arborizations, which present space-clamp limitations during whole-cell voltage-clamp recordings(<xref ref-type="bibr" rid="c4">Bar-Yehuda &amp; Korngreen, 2008</xref>). To mitigate these issues, we followed established protocols to isolate axonal blebs from cortical pyramidal neurons(<xref ref-type="bibr" rid="c38">Hu &amp; Shu, 2012</xref>). These spherical, membrane-bound blebs form at the cutting surface of cortical slices and are readily visualized (<xref rid="fig7" ref-type="fig">Figure 7A</xref>). Sodium currents recorded from axon blebs were voltage-dependent and sensitive to tetrodotoxin (TTX), confirming that they were primarily mediated by Nav channels(<xref ref-type="bibr" rid="c38">Hu &amp; Shu, 2012</xref>).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7</label>
<caption>
<title>PRRT2 deficiency impairs the regulation of Nav channel slow inactivation and neuronal resilience in mice.</title>
<p><bold>(A)</bold> Schematic showing the isolated axonal bleb recording in cortical neuron (left) and the representative brightfield image for the axonal bleb in brain slice (right). The arrow indicates an axonal bled. Scale bar, 20 μm. <bold>(B)</bold> Sodium current density recorded in isolated axonal blebs from wild-type (WT) and <italic>Prrt2</italic>-mutant mice (WT: <italic>n</italic> = 18 blebs from 7 mice, <italic>Prrt2</italic>-mutant: <italic>n</italic> = 20 blebs from 8 mice). <bold>(C)</bold> Protocol for assessing Nav channel slow-inactivation (upper) and the representative traces of the sodium currents evoked by conditioning depolarization pulse and test pulses (bottom). Scale bar, 0.5 nA by 5 ms. <bold>(D)</bold> Fraction of available Nav channels after 5-s depolarization (WT: <italic>n</italic> = 18 blebs from 7 mice, <italic>Prrt2</italic>-mutant: <italic>n</italic> = 19 blebs from 8 mice). <bold>(E)</bold> Schematic illustration of the cortical electrostimulation and EEG recording in mice. Ref, reference electrode. Gnd, ground electrode. Stim, Stimulation. <bold>(F)</bold> Illustration showing the experimental schedule and the stimulation parameters. Stimulation was delivered once daily with stepwise increases in current intensity. <bold>(G)</bold> Representative traces and power of EEG signals in wild-type and <italic>Prrt2</italic>-mutant mice before and after 2-s cortical stimulation. After-discharges were indicated by the arrow and red line. Scale bar: 0.2 mV. Electrical stimulation (120 µA) was applied during 60–62 s period, where the stimulus-induced artifacts were removed prior to analysis. <bold>(H)</bold> Threshold of electrical stimulation to induce after-discharges in WT and <italic>Prrt2</italic>-mutant mice (WT: <italic>n</italic> = 16 mice, <italic>Prrt2</italic>-mutant: <italic>n</italic> = 8 mice). <bold>(I)</bold> Percentage of after-discharge occurrence in WT and <italic>Prrt2</italic>-mutant mice after electrical stimulation (WT: <italic>n</italic> = 16, <italic>Prrt2</italic>-mutant: <italic>n</italic> = 8). Data were presented as mean ± s.e.m. Two-tailed, unpaired Student’s <italic>t</italic>-test was used in (B and D) and two-tailed, unpaired Mann-Whitney test was used in (H). In (I), the main effect of group was assessed using two-way ANOVAs. ****<italic>P</italic> &lt; 0.0001, n.s., not significant.</p>
</caption>
<graphic xlink:href="678785v1_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig7-s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7-figure supplement 1.</label>
<caption><title>Protein levels of Nav1.2 are unchanged in brain tissue from <italic>Prrt2</italic>-mutant mice.</title>
<p><bold>(A and B)</bold> Immunoblots (A) and quantifications (B) of Nav1.2 proteins in brain tissue of wildtype (WT) and <italic>Prrt2</italic>-mutant mice (<italic>n</italic> = 3 mice). Data were presented as mean ± s.e.m. Two-tailed, paired Student’s <italic>t</italic>-test was used in (B) to determine the statistical significance. n.s., not significant.</p></caption>
<graphic xlink:href="678785v1_fig7-s4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>PRRT2 deficiency did not affect Nav1.2 protein expression in forebrain tissues (Figure 7-figure supplement 7A and B), nor did it alter the sodium current density in cortical axonal blebs (<xref rid="fig7" ref-type="fig">Figure 7B</xref>). Because long-term voltage-clamp recordings from isolated axonal bleb are technically challenging, we employed a simplified protocol to assess Nav channel slow inactivation, using a holding potential of −70 mV to approximate the resting membrane potential of cortical neurons. In this protocol, a single 5-s depolarization to 0 mV was applied, and the fraction of available Nav channels was determined after a 10-ms hyperpolarization (<xref rid="fig7" ref-type="fig">Figure 7C</xref>).</p>
<p>Approximately 20% of Nav channels in wild-type blebs remained available, compared to ∼40% <italic>Prrt2</italic>-mutant blebs (<xref rid="fig7" ref-type="fig">Figures 7C</xref> and <xref rid="fig7" ref-type="fig">D</xref>), indicating that during sustained depolarization, fewer Nav channels in the <italic>Prrt2</italic>-mutant group entered the slow-inactivated state. Notably, because the proportion of channels entering slow inactivation differed substantially between wild-type and <italic>Prrt2</italic>-mutant groups, direct comparison of recovery kinetics was not feasible and was therefore not performed. Nevertheless, these findings provide direct evidence that endogenous PRRT2 is required for effective regulation of Nav channel slow inactivation in cortical neurons.</p>
</sec>
<sec id="s2h">
<title>PRRT2 deficiency compromises cortical resilience in awake mice</title>
<p>Slow inactivation of Nav channels is essential for limiting neuronal excitability during episodes of aberrant hyperactivity in the neuronal networks(<xref ref-type="bibr" rid="c83">Zang, Marder, &amp; Marom, 2023</xref>). Given the ability of PRRT2 to regulate this process, we hypothesized that PRRT2 might contribute to cortical resilience in awake mice, a property reflecting the resistance of the cerebral cortex to pathological perturbations.</p>
<p>To assess this, we employed a stimulation-response paradigm in which stimulation electrodes were implanted into the left hemisphere of the cerebral cortex, targeting both the sensory and visual cortices, while EEG recording electrodes were placed in the contralateral hemisphere that receives projections from the stimulation region (<xref rid="fig7" ref-type="fig">Figure 7E</xref>). We applied pulsed electrostimulations (1-ms width at 60 Hz for 2 s) to the cortex of mice once daily with stepwise increases in intensity, and the minimal current required to evoke after-discharges (ADs) in the contralateral cortex was determined in each animal (<xref rid="fig7" ref-type="fig">Figure 7F</xref>). The current threshold required to induce after-discharges serves as a functional indicator of cortical resilience to aberrant excitatory inputs(<xref ref-type="bibr" rid="c9">Blume, Jones, &amp; Pathak, 2004</xref>).</p>
<p><italic>Prrt2</italic>-mutant mice exhibited significantly lower stimulation thresholds for evoking after-discharges compared to wild-type controls (<xref rid="fig7" ref-type="fig">Figures 7G</xref> and <xref rid="fig7" ref-type="fig">H</xref>). Specifically, stimulation at an average intensity of 85 µA reliably induced after-discharges in <italic>Prrt2</italic>-mutant mice, whereas a significantly higher intensity (190 μA) was required to elicit similar responses in wild-type mice (<xref rid="fig7" ref-type="fig">Figures 7H</xref> and <xref rid="fig7" ref-type="fig">I</xref>), suggesting that PRRT2 is essential for maintaining cortical resilience in response to excitatory perturbations.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>In this study, we identified PRRT2 as a crucial auxiliary factor of Nav channel slow inactivation. We demonstrate that PRRT2 exerts a dual action by both facilitating the transition of Nav channels into a slow-inactivated state and delaying their recovery. Importantly, this regulatory action is evolutionarily conserved, and requires the integrity of the PRRT2’s C-terminal region. Using both <italic>Prrt2-V5</italic> knock-in and <italic>Prrt2</italic>-mutant mouse models, we provide compelling evidence that PRRT2 forms a molecular complex with Nav channels <italic>in vivo</italic> and plays an essential role in modulating their slow inactivation, thereby contributing to the maintenance of neuronal resilience to perturbations.</p>
<p>In eukaryotic Nav channels, ion permeability is regulated through at least four distinct and coordinated gating mechanisms: voltage-gated activation and deactivation, fast inactivation, and slow inactivation(<xref ref-type="bibr" rid="c11">Catterall, 2023</xref>). Slow inactivation, an evolutionarily conserved intrinsic property of Nav channels, is mediated by conformational rearrangements and has distinct molecular determinants from those governing fast inactivation(<xref ref-type="bibr" rid="c54">Payandeh, 2018</xref>; <xref ref-type="bibr" rid="c62">Silva, 2014</xref>; <xref ref-type="bibr" rid="c70">Vilin &amp; Ruben, 2001</xref>).</p>
<p>Previous studies have suggested that slow inactivation involves conformational changes at multiple structural regions of the Nav channels. The external pore mouth(<xref ref-type="bibr" rid="c3">Balser et al., 1996</xref>; <xref ref-type="bibr" rid="c78">Xiong et al., 2006</xref>), the selectivity filter(<xref ref-type="bibr" rid="c15">Chatterjee et al., 2018</xref>; <xref ref-type="bibr" rid="c65">Todt, Dudley, Kyle, French, &amp; Fozzard, 1999</xref>), the S6 segments(<xref ref-type="bibr" rid="c14">Chancey, Shockett, &amp; O’Reilly, 2007</xref>; Y. <xref ref-type="bibr" rid="c17">Chen, Yu, Surmeier, Scheuer, &amp; Catterall, 2006</xref>; S. Y. <xref ref-type="bibr" rid="c74">Wang &amp; Wang, 1997</xref>), and the regions within S4, S4-S5 linker and S5 segments(<xref ref-type="bibr" rid="c5">Bendahhou, Cummins, Kula, Fu, &amp; Ptacek, 2002</xref>; <xref ref-type="bibr" rid="c18">Cummins &amp; Sigworth, 1996</xref>; <xref ref-type="bibr" rid="c33">Hayward et al., 1999</xref>; <xref ref-type="bibr" rid="c48">Mitrovic, George, &amp; Horn, 2000</xref>; D. W. <xref ref-type="bibr" rid="c72">Wang, Makita, Kitabatake, Balser, &amp; George, 2000</xref>), have been implicated in modulating slow inactivation of Nav channels. The present study did not directly verify whether these structural regions mediated the effect of PRRT2 on Nav channel slow inactivation. However, insights from molecular modeling of protein complex provide valuable clues. By using the recently developed AlphaFold3(<xref ref-type="bibr" rid="c1">Abramson et al., 2024</xref>), we modeled a putative interaction between PRRT2 and the Nav channel. The predicted complex suggests that the C-terminal region of PRRT2 interacts with the S3 segment of domain IV (DIV-S3) of Nav isoforms. This raises the possibility that residues within DIV-S3 may serve as critical determinants for the regulatory effects of PRRT2 on Nav channel slow inactivation.</p>
<p>The role of PRRT2 in the regulation of Nav channel slow inactivation appears to be unique compared to known regulators such as SCN1B and FHFs. The modulatory effects of the SCN1B on Nav channel inactivation were initially observed in <italic>Xenopus</italic> oocytes(<xref ref-type="bibr" rid="c71">Wallner, Weigl, Meera, &amp; Lotan, 1993</xref>), where it was found to influence sodium currents. Subsequent studies proposed that the SCN1B impedes slow inactivation, a hypothesis later confirmed in mammalian cells co-expressing Nav1.4 and SCN1B(<xref ref-type="bibr" rid="c76">Webb et al., 2009</xref>). However, its regulatory effects on slow inactivation were varied across Nav isoforms(<xref ref-type="bibr" rid="c34">He &amp; Soderlund, 2014</xref>; <xref ref-type="bibr" rid="c43">Makita, Bennett, &amp; George, 1996</xref>; <xref ref-type="bibr" rid="c69">Vilin et al., 1999</xref>; <xref ref-type="bibr" rid="c79">Xu et al., 2007</xref>). In this study, we observed little effect of SCN1B on the onset and recovery of slow inactivation in Nav1.2, consistent with previous findings(<xref ref-type="bibr" rid="c79">Xu et al., 2007</xref>). In contrast to SCN1B, PRRT2 exerts a more consistent effect across Nav isoforms, enhancing slow inactivation regardless of the specific Nav subtype.</p>
<p>FHF proteins (FHF1-4, also known as FGF11-14) constitute a subfamily of FGFs that lack a secretion signal and function distinctly from traditional FGFs(<xref ref-type="bibr" rid="c50">Olsen et al., 2003</xref>). Previous studies demonstrated that FHFs mediate a rapid-onset, long-term inactivation, which differs mechanically from traditional slow inactivation(<xref ref-type="bibr" rid="c21">Dover et al., 2010</xref>). Unlike the FHF2A-mediated long-term inactivation, which can be triggered by a brief 2-ms depolarization, PRRT2 requires a longer depolarization to affect the onset of slow inactivation of Nav channels. Additionally, PRRT2 significantly delays the Nav channel recovery from slow inactivation induced by 5-second depolarization, whereas FHF2A has little effect on this process. These findings suggest that PRRT2 and FHF2A modulate Nav channel inactivation through different mechanisms.</p>
<p>In mammals, Nav channel isoforms (Nav1.1–1.9) are distributed across the nervous system, skeletal muscle, heart and secretory glands(<xref ref-type="bibr" rid="c19">Cusdin, Clare, &amp; Jackson, 2008</xref>). Although we have shown that PRRT2 exerts a consistent effect on slow inactivation across various Nav channel isoforms <italic>in vitro</italic>, the regulation of Nav channel slow inactivation is likely to be more complex under physiological conditions. PRRT2 is predominantly expressed in the nervous system(<xref ref-type="bibr" rid="c16">W. J. Chen et al., 2011</xref>), with enrichment in excitatory neurons(<xref ref-type="bibr" rid="c63">Tan et al., 2018</xref>), making it unlikely to directly modulate Nav1.4 and Nav1.5 channels, which are primarily expressed in skeletal muscle and cardiac tissue, respectively(<xref ref-type="bibr" rid="c19">Cusdin et al., 2008</xref>). A similar rationale applies to Nav1.1, which is largely confined to inhibitory interneurons(<xref ref-type="bibr" rid="c82">Yu et al., 2006</xref>), where PRRT2 expression is minimal or absent.</p>
<p>The partial mismatch between PRRT2 and Nav channel expression <italic>in vivo</italic> raises an important question that how Nav channel slow inactivation is regulated in cells that do not express PRRT2. One possibility is the expression of alternative regulators, such as TRARG1 or TMEM232, both of which belong to the DspB family and are expressed in tissues distinct from PRRT2(<xref ref-type="bibr" rid="c22">Ehrlich, Lacey, &amp; Ehrlich, 2020</xref>; <xref ref-type="bibr" rid="c51">Oort, Warden, Baumann, Knotts, &amp; Adams, 2007</xref>; <xref ref-type="bibr" rid="c60">Santana-Varela et al., 2021</xref>; <xref ref-type="bibr" rid="c61">Shibata et al., 2007</xref>). These proteins may serve analogous functions in modulating Nav channel slow inactivation. Another possibility is that certain PRRT2-negative cells have a reduced requirement for Nav channel slow inactivation modulation due to their intrinsic rhythmic firing properties. For instance, in the cerebellar cortex, the PRRT2 is absent in Purkinje cells, which exhibit repetitive firing(<xref ref-type="bibr" rid="c42">Lu et al., 2021</xref>). In such rhythmic firing cells, strong regulation of Nav channel slow inactivation may be undesirable, as excessive accumulation of inactivated Nav channels could disturb the regular firing patterns of these cells.</p>
<p>Given the critical role of PRRT2 in regulating Nav channel slow inactivation, its deficiency is expected to alter neuronal responses to intense and prolonged activity, thereby contributing to dysfunction in the central nervous system. Evidence from both animal models and clinical studies supports this hypothesis. In the present study, we found that PRRT2 deficiency impairs slow inactivation of Nav channels in cortical neurons, leading to reduced resistance to pathological perturbations, as evidenced by an increased susceptibility to after-discharge induction in awake mice. Previous studies have also reported that loss-of-function mutations or knockout of PRRT2 increase intrinsic excitability in cerebellar granule cells and promote spreading depolarization in the cerebellar cortex(<xref ref-type="bibr" rid="c8">Binda, Valente, Marte, Baldelli, &amp; Benfenati, 2021</xref>; <xref ref-type="bibr" rid="c42">Lu et al., 2021</xref>). In humans, <italic>PRRT2</italic> mutations are associated with infantile convulsions(<xref ref-type="bibr" rid="c41">Lee et al., 2012</xref>), paroxysmal dyskinesia(<xref ref-type="bibr" rid="c16">W. J. Chen et al., 2011</xref>; <xref ref-type="bibr" rid="c73">J. L. Wang et al., 2011</xref>), and hemiplegic migraine(<xref ref-type="bibr" rid="c56">Riant et al., 2022</xref>), all of which are linked to dysfunction in neuronal network excitability. Based on these lines of evidence, we conclude that PRRT2 deficiency in excitatory neurons impairs Nav channel slow inactivation, thereby compromising neuronal resilience to aberrant excitability and ultimately contributing to these episodic neurological disorders.</p>
<p>Together, the identification of PRRT2 as an auxiliary factor regulating Nav channel slow inactivation has significant implications for understanding the fine-tuning mechanisms of Nav channel function. Additionally, these findings may inform the development of novel therapeutic strategies for treating neurological disorders associated with excitability dysregulation.</p>
<sec id="s3a">
<title>Limitations of the study</title>
<p>While our study successfully identifies the functional domain of PRRT2, the specific interaction site on the Nav channel that binds PRRT2 and mediates the regulation of slow inactivation remains unknown. Further investigations are required to map the PRRT2 binding region on Nav channels and to determine how mutations at these sites influence PRRT2-dependent modulation of slow inactivation. Cryo-electron microscopy (cryo-EM) is a promising approach for resolving the structural details of the Nav-PRRT2 complex, particularly given recent advancements in determining high-resolution structures of various Nav channel isoforms and their complexes with auxiliary factors(<xref ref-type="bibr" rid="c40">Jiang et al., 2020</xref>; <xref ref-type="bibr" rid="c52">Pan et al., 2019</xref>; <xref ref-type="bibr" rid="c53">Pan et al., 2021</xref>). A detailed structural characterization of the Nav-PRRT2 interaction would provide critical insights into the molecular mechanisms governing Nav channel slow inactivation.</p>
</sec>
</sec>
<sec id="s4">
<title>Materials and methods</title>
<sec id="s4a">
<title>Molecular cloning</title>
<p>Mammalian expression constructs were generated using the pCAGIG backbone (Addgene, 11159), which contains an internal ribosome entry site (IRES) followed by EGFP(<xref ref-type="bibr" rid="c45">Matsuda &amp; Cepko, 2004</xref>). Coding sequences for full-length or truncated protein-of-interests (POIs) were inserted in the pCAGIG vector using a seamless cloning method (Beyotime, D7010). The POIs including human PRRT2 (hPRRT2), hPRRT2(1–268), hPRRT2(250–340), mouse PRRT2 (mPRRT2), mPRRT2(222–346), mPRRT2(256–346), mPRRT2(1–266), zebrafish PRRT2 (zfPRRT2), mouse SCN1B, mouse FHF2A, mouse TRARG1 and mouse TMEM233. A PRRT2 chimeric construct was generated by fusing the N-terminal fragment of human PRRT2 (hPRRT2(1–222)) with the C-terminal region of zebrafish PRRT2 (zPRRT2(110–226)), and cloning the resulting sequence into pCAGIG vector. Plasmids encoding human PRRT2(<xref ref-type="bibr" rid="c16">W. J. Chen et al., 2011</xref>) were kindly provided by Dr. Zhi-Ying Wu’s Laboratory (Zhejiang University). Plasmids of pCAG-Flag-Nav1.2(<xref ref-type="bibr" rid="c52">Pan et al., 2019</xref>) and pCAG-Flag-Nav1.1(<xref ref-type="bibr" rid="c53">Pan et al., 2021</xref>) were provided by Huai-Zong Shen’s Laboratory (Westlake University). All constructs generated in this study were verified by Sanger sequencing (BioSune, Boshang Biology Technology, Shanghai).</p>
</sec>
<sec id="s4b">
<title>Cell culture and heterologous expression</title>
<p>HEK293T cell lines stably expressing human Nav1.2 or Kv1.4 respectively and CHO cell lines stably expressing human Nav1.1, Nav1.4 or Nav1.5 were obtained from the laboratory of ICE Bioscience Inc. Wild-type HEK293T cells (SCSP-502) used for transient transfection were obtained from Cell Bank/Stem Cell Bank of Chinese Academy of Sciences. All cells were cultured in Dulbecco’s modified Eagle medium (DMEM; Gibco, 11995065) supplemented with 10% fetal bovine serum (FBS; Gibco,10099141) and penicillin (50 U/mL)-streptomycin (50 μg/mL) (Gibco,15140163), and maintained at 37 °C in a humidified incubator with 5% CO<sub>2</sub>. The HEK293T cell line used in this study is of female origin and tested negative for mycoplasma contamination.</p>
<p>For heterologous protein expression in whole-cell voltage-clamp recording, 2 μg of plasmid DNA was transfected into HEK293T or CHO cells using Lipofectamine 2000 (ThermoFisher, 11668-019) according to the manufacturer’s instructions. For co-immunoprecipitation assays, 2–3 μg of total plasmid DNA (encoding two proteins of interest) was used for co-transfection. Four hours after the transfection, the medium was replaced with fresh growth medium, and cells were maintained for an additional 20 hours before subsequent experiments.</p>
</sec>
<sec id="s4c">
<title>Animals</title>
<p><italic>Prrt2</italic>-mutant mice, carrying a premature stop codon in exon 2 of the <italic>Prrt2</italic> gene(<xref ref-type="bibr" rid="c63">Tan et al., 2018</xref>), were used in electrophysiological recording experiments.</p>
<p><italic>Prrt2</italic>-<italic>V5</italic> knock-in mice, used for co-immunoprecipitation (Co-IP) experiments, were generated in this study via CRISPR/Cas9 technology(<xref ref-type="bibr" rid="c81">Yang et al., 2014</xref>). Briefly, single-guide RNA (sgRNA: 5’-TCTCCCACAGTGTATAAGTG-3’) targeting the location nearby the stop codon of <italic>Prrt2</italic> gene allele, together with a single-stranded DNA donor template encoding a V5 tag flanked by 53-bp homology arms (ssDNA: 5’-CTTCCCTGTC TGTCTTTCCC TCTCCTCTCC CACAGTGTAT AAGGGCAAGC CCATCCCCAA CCCCCTGCTG GGCCTGGACA GCACCTGAGG GGCTCTGCCC TGCATTCCAA GACTTTTCTT CCTGTTGG-3’) and Cas9 mRNA, were microinjected into zygotes from fertilized C57BL/6J mice. The injected zygotes were implanted into pseudopregnant female mice. Offspring were screened for correct insertion of the V5 tag immediately upstream of the <italic>Prrt2</italic> stop codon by PCR, and the insertion was subsequently verified by Sanger sequencing. Positive founder (F0) mice were crossed with C57BL/6J mice to establish the <italic>Prrt2</italic>-<italic>V5</italic> knock-in line.</p>
<p>Both <italic>Prrt2</italic>-mutant and <italic>Prrt2</italic>-<italic>V5</italic> lines were backcrossed onto the C57BL/6J background for more than 10 generations. C57BL/6J mice used for breeding were obtained from the Shanghai Laboratory Animal Center (SLAC), Chinese Academy of Science.</p>
<p>Mice were housed in a 12-h light-dark cycle (light on at 7:00 a.m.) with ad libitum access to food and water. All procedures involving animals were approved by the Animal Care and Use Committee of the Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences (Approval number, NA-009-2022). Both male and female mice were used in experiments.</p>
</sec>
<sec id="s4d">
<title>Whole-cell voltage clamp recording for sodium currents in cell lines</title>
<p>Sodium currents were recorded from HEK293T or CHO cell lines stably expressing individual human Nav channel isoforms (ICE Bioscience Inc.). Cells were transfected with plasmids as described in the main text. Twenty-four hours after transfection, cells were trypsinized and replated at lower density onto poly-D-lysine-coated coverslips. EGFP-positive cells were selected for recording 24 hours later.</p>
<p>Whole-cell voltage-clamp recordings were conducted at room temperature (23-24 °C). The bath solution contained (in mM): 50 NaCl, 90 choline chloride, 3.5 KCl, 1 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 10 D-Glucose, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, and 10 HEPES (pH adjusted to 7.4 with NaOH). The internal pipette solution contained (in mM): 50 CsCl, 60 CsF, 10 NaCl, 20 EGTA, 10 HEPES (pH adjusted to 7.2 with CsOH). The osmolarity of the external and internal solutions was adjusted to 300 and 290 mOsmol/kg, respectively.</p>
<p>Pipette electrodes were pulled from borosilicate glass capillary (Sutter Instruments, BF150-86-10) using a horizontal puller (P-97, Sutter Instruments). The pipette resistance was approximately 2 MΩ when filled with internal pipette solution. After whole-cell configuration was achieved, cells were allowed to equilibrate for 5 minutes prior to recording. Series resistance was compensated by 80% to minimize voltage errors. Currents were recorded with an amplifier (HEKA, EPC-10), sampled at 10 kHz, and acquired using Patchmaster (HEKA, v2×92).</p>
</sec>
<sec id="s4e">
<title>Fast inactivation assay for Nav channels</title>
<p>To assess the fast inactivation kinetics of Nav channels, sodium currents were evoked by 20ms depolarizing pulse to 0 mV from a holding potential of −120 mV. The time constant (tau) of current decay was obtained by mono-exponential fitting of the current trace.</p>
<p>Recovery from fast inactivation was measured using a two-pulse protocol, in which a 10-ms depolarizing pulse to 0 mV (P1) was followed by a variable-duration recovery period at −120 mV and a second 10-ms test pulse at 0 mV (P2). Recovery was quantified as the normalized peak current of P2 relative to P1.</p>
</sec>
<sec id="s4f">
<title>Slow inactivation assay for Nav channels</title>
<p>To evaluate the development of slow inactivation of Nav channels, a series of conditioning prepulses of increasing duration at 0 mV was applied, followed by a brief 10-ms recovery at −120 mV and a 10-ms test pulse at 0 mV. Inter-sweep intervals were set at 15 s. Available fractions of Nav channels were assessed by normalizing the peak currents in the test pulse to that of the conditioning pulse.</p>
<p>For slow inactivation recovery, a 5-s conditioning pulse at 0 mV was followed by variable recovery durations at −120 mV, then a 10-ms test pulse at 0 mV. Inter-sweep interval was 15 s. In experiments assessing the effect of zebrafish PRRT2 on slow inactivation recovery, a modified protocol was used to avoid cumulative inactivation. Within a single sweep, a 5-s depolarization was followed by a series of 10-ms test pulses to 0 mV, each separated by progressively longer recovery periods at −120 mV(<xref ref-type="bibr" rid="c76">Webb et al., 2009</xref>).</p>
</sec>
<sec id="s4g">
<title>Steady-state slow inactivation assay for Nav channels</title>
<p>To measure steady-state slow inactivation, 10-s conditioning pulses ranging from −110 to −10 mV (in 10 mV increments) were applied, followed by a 10-ms hyperpolarizing step to −120 mV and subsequently a 5-ms test pulse to 0 mV. The peak test current was normalized to the maximum sodium current recorded across all conditions in the protocol and reported as I/I<sub>max</sub>.</p>
</sec>
<sec id="s4h">
<title>Whole-cell voltage clamp recording for potassium currents in cell lines</title>
<p>HEK-293 cells stably expressing Kv1.4 channels (ICE Bioscience Inc.) were used to examine the effects of PRRT2 on Kv1.4 channel inactivation. Plasmid transfection and cell preparation were conducted as described in the sodium current recordings section.</p>
<p>For potassium current recording, the external bath solution contained (in mM): 140 NaCl, 3.5 KCl, 1 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 10 D-Glucose, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 10 HEPES (pH adjusted to 7.4 with NaOH). The internal pipette solution contained (in mM): 20 KCl, 115 K-aspartate, 1 MgCl<sub>2</sub>, 5 EGTA, 2 Na<sub>2</sub>-ATP, 10 HEPES (pH adjusted to 7.2 with KOH).</p>
</sec>
<sec id="s4i">
<title>Inactivation assay for Kv1.4 channels</title>
<p>Unlike Nav channels, the ‘fast’ (N-type) and ‘slow’ (C-type) inactivation components of Kv1.4 channels cannot be easily separated by brief hyperpolarization due to the slow recovery kinetics of N-type inactivation. As such, both components were assessed together in this study. To assess the onset of Kv1.4 inactivation, cells were held at −80 mV and subjected to a series of depolarizing prepulses to +40 mV with increasing durations, followed by a 20-ms test pulse at +40 mV. Inter-sweep interval was 15 s. The fraction of available Kv1.4 channels during the test pulse was calculated by normalizing the peak test current to the peak current during the prepulse step.</p>
<p>To evaluate recovery kinetics, a 5-s depolarizing pulse to +40 mV was applied to induce inactivation, followed by a series of test pulses (40 mV, 20 ms), each separated by progressively increasing recovery periods at −80 mV.</p>
</sec>
<sec id="s4j">
<title>Slice preparation</title>
<p>Mice (postnatal day 14-20) were anesthetized with 4% isoflurane. The brain tissues were rapidly extracted and immersed in ice-cold sucrose-based cutting solution containing (in mM): 2.5 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 26 NaHCO<sub>3</sub>, 10 MgSO<sub>4</sub>, 0.5 CaCl<sub>2</sub>, 10 D-Glucose, 205 sucrose, 1 sodium pyruvate, 1.3 sodium L-ascorbate. Coronal cortical slices (250 μm) were prepared using a vibratome (Leica, VT1200S).</p>
<p>Slices were then transferred immediately to an incubation beaker containing aerated artificial cerebrospinal fluid (ACSF) composed of (in mM): 126 NaCl, 2.5 KCl, 2 MgSO<sub>4</sub>, 2 CaCl<sub>2</sub>, 26 NaHCO<sub>3</sub>, 1.25 NaH<sub>2</sub>PO<sub>4</sub> and 25 dextrose (pH 7.4, 315 mOsm). Slices were incubated at 35 °C for 30 min, then maintained in the same solution at room temperature until use. The oxygenated ACSF was equilibrated with 95% O<sub>2</sub> and 5% CO<sub>2</sub>.</p>
</sec>
<sec id="s4k">
<title>Electrophysiological recording in isolated axonal blebs</title>
<p>Slices were transferred to a recording chamber and stabilized with a platinum anchor grid during recording. Resealed axonal ends (“blebs”) in the cerebral cortex were visualized using an upright infrared differential interference contrast (IR-DIC) microscope. Individual blebs were mechanically isolated by sweeping a cutting pipette beneath it, and subsequently patched with glass electrodes (resistance ∼7 MΩ).</p>
<p>For sodium current recordings, pipettes were filled with a potassium gluconate-based internal solution containing (in mM): 130 K-gluconate, 1 MgCl<sub>2</sub>, 11 EGTA, 1 CaCl<sub>2</sub>, 1 KCl, 2 Mg-ATP, 0.3 Na-GTP, 10 HEPES (pH adjusted to 7.2, ∼290 mOsm), supplemented with 2 mM TEA-Cl. The external ACSF solution was supplemented with 5 mM 4-Aminopydine (4-AP) and 200 μM CdCl<sub>2</sub> to block K<sup>+</sup> and Ca<sup>2+</sup> currents, respectively.</p>
<p>Whole-cell voltage-clamp recordings were performed using a MultiClamp amplifier (Molecular Devices, 700B). Currents were filtered at 4 kHz (low-pass) and digitized at 20 kHz via a Digidata interface (Molecular Devices, 1440A). Series resistance was compensated by 80% to minimize voltage errors. Leak currents were subtracted by using an online P/4 procedure. The holding potential was set to −70 mV, approximating the resting membrane potential of cortical neurons. To assess sodium current density, a hyperpolarization prepulse to −110 mV (200 ms) was used to remove inactivation, followed by a 20-ms depolarization to 0 mV. Sodium current density (nA/pF) was calculated by normalizing peak current to bleb capacitance. To evaluate Nav channel slow inactivation a single 5-s depolarizing pulse (0 mV) was applied to induce slow inactivation followed by a test pulses (0 mV, 20 ms) separated by 10-ms recovery intervals at −70 mV. The fraction of available Nav channels was calculated by normalizing the peak current amplitude of each test pulse to the peak current measured at the onset of the 5-s depolarization.</p>
</sec>
<sec id="s4l">
<title>Co-immunoprecipitation in transfected HEK293T cells</title>
<p>In co-immunoprecipitation experiments, one protein-of-interest was tagged with an HA epitope and the other with a Flag epitope. The pCAGIG vector bearing either a HA or Flag tag alone was used as a control in paired constructs. HEK293T cells transfected with a pair of constructs were harvested 24 hours post-transfection for protein expression. Cells were lysed in ice-cold lysis buffer (20 mM Tris-HCl, 150 mM NaCl, 0.5% n-Dodecyl β-D-maltoside (DDM, Anatrace, D310), and protease inhibitor cocktail (Selleckchem, B14002)) with gentle agitation at 4 °C for 2 hours. Lysates were centrifuged at 20,000 x g for 20 minutes at 4 °C to remove insoluble debris. The supernatant was transferred to a fresh tube and kept on ice. Protein concentration of supernatant was determined using a colorimetric bicinchoninic acid (BCA) assay (Beyotime, P0012S). For each immunoprecipitation (IP), 400 μg of proteins was incubated with 30 μL of anti-HA nanobody magnetic beads (AlfaLifeBio, KTSM1335) or anti-Flag magnetic beads (Bimake, B26102) at 4 °C with rotation for 1 hour. Beads were then separated with DynaMag spin and washed three times with wash buffer (20 mM Tris-HCl, 150 mM NaCl, 0.05% DDM). The captured proteins were eluted with 25 μL SDS-PAGE loading buffer containing 100 mM DTT, followed by heating at 45 °C for 10 min. Samples were stored at −20 °C prior to western blot analysis.</p>
</sec>
<sec id="s4m">
<title>Co-immunoprecipitation in mouse brain tissues</title>
<p>Brain tissues (∼100 mg per sample) were freshly dissected from wild-type or <italic>Prrt2</italic>-<italic>V5</italic> knockin mice, and homogenized on ice using glass homogenizers in 1 mL of Tris-buffered saline (TBS, 20 mM Tris-HCl, 150 mM NaCl, protease inhibitor cocktail). The homogenates were centrifuged at 800 x g for 10 min at 4 °C to remove nuclei and cell debris. Supernatants were subjected to centrifugation at 40,000 x g for 45 minutes at 4 °C to isolate membrane fractions. The resulting membrane-enriched pellets were resuspended in TBS and solubilized in lysis buffer containing 0.3% DDM for 3 hours at 4 °C. Lysates were then cleared by centrifugation at 20,000 x g for 20 minutes at 4 °C. Protein concentration was measured via BCA assay. For each IP, ∼200 μg of proteins was incubated with 30 μL of V5-Trap magnetic beads (Chromotek, v5tma-20) at 4 °C with rotation for 1.5 hours. Beads were washed three times with wash buffer (20 mM Tris-HCl, 150 mM NaCl, 0.15% DDM), and bound proteins were eluted with 25 μL SDS-PAGE loading buffer containing 100 mM DTT, followed by heating at 45 °C for 10 min. Eluates were kept at −20 °C until use in western blotting.</p>
</sec>
<sec id="s4n">
<title>Western blotting</title>
<p>Protein samples were separated using 4-12% PAGE Gel (Nanjing ACE Biotechnology, ET15412L) in MES-SDS running buffer at 140 V for 60 minutes. Proteins were transferred onto polyvinylidene difluoride (PVDF) membranes at 300 mA for 2 hours at 4 °C. The PVDF membranes were blocked in 5% nonfat milk in TBST (TBS with 0.1% Tween-20) for 1 hour at room temperature, followed by incubation with indicated primary antibodies overnight at 4 °C with gentle agitation.</p>
<p>After three washes in TBST, membranes were incubated with HRP-conjugated secondary antibodies for 2 hours at room temperature. Following another three washes, chemiluminescent substrate (TIANGEN Biotech, PA112) was applied, and signals were detected using a blot imaging system (Analytikjena, ChemStudio 815). Densitometric analysis of protein bands was performed using QuantityOne software (Biorad, Quantity One 1-D analysis, v4.6.2). The primary antibodies we used in western blotting were as follow: Anti-human PRRT2 (Atlas antibodies, HPA014447), Anti-Nav1.2 (Alomone Labs, ASC-002), Anti-Nav1.1 (Alomone Labs, ASC-001), Anti-HA-Tag (Cell signaling technology, 3724S), Anti-GAPDH-HRP (KangChen Bio-tech,KC-5G5), Anti-ATP1B2 (Abcam, ab185210), Anti-mouse PRRT2 (Wiiget Biotech, Rp3246) and Anti-β Actin-HRP (Cell signaling technology, 5125S).</p>
</sec>
<sec id="s4o">
<title>Animal Surgery</title>
<p>Mice were anesthetized with isoflurane (RWD life science, R510-22-10), using 4% for induction and 2% for maintenance. Body temperature was maintained throughout the procedure with a heating pad. Meloxicam (5 mg/kg, subcutaneous) was administered preoperatively for analgesia.</p>
<p>After securing the mice in a stereotaxic frame (RWD life science, Model 68528), 0.25% bupivacaine was locally injected at the incision sites for perioperative analgesia, and ophthalmic ointment was applied to protect the cornea. A midline incision was made to expose the skull, which was cleaned with 2% hydrogen peroxide using sterile cotton swabs to remove connective tissue. The skull surface was leveled to a stereotaxic plane, and the bregma was identified and marked. Once dry, the exposed skull was coated with a light-curing self-etch adhesive (3M ESPE Single Bond Universal).</p>
<p>Two small craniotomies (∼0.6 mm in diameter) were made over the left sensory cortex (anterior-posterior (AP) −0.8 mm; medial-lateral (ML) 1.5 mm) and visual cortex (AP −3.5 mm, ML 1.5 mm) for the insertion of bipolar stimulation electrodes (180 μm in diameter), which were implanted to a depth of −0.6 mm from the dura. Stainless steel screws were used as EEG electrodes: one was implanted into the right visual cortex (AP −2.25 mm, ML −1.5 mm), and the second into the right cerebellar vermis to serve as the reference. An additional screw was placed in the left cerebellar hemisphere as the ground. The electrodes and a custom-made head plate were affixed to the skull using dental cement.</p>
<p>Post-operatively, meloxicam (5 mg/kg, subcutaneously) was administered once daily for 3 consecutive days. Mice were allowed to recover for one week prior to electrical stimulation and EEG recording.</p>
</sec>
<sec id="s4p">
<title>Electrostimulation and EEG recording in the cerebral cortex</title>
<p>One week after surgery, mice were habituated to a custom-built head plate holder for 30 minutes per day over three consecutive days prior to testing.</p>
<p>For stimulation experiments, the pre-implanted electrodes were connected to a stimulus isolator (AMPI, ISO Flex). Electrical pulses (1 ms pulse width, 60 Hz frequency, 2 s duration) were delivered through the isolator and controlled via TTL signals from a pulse generator (RWD life science, R820). EEG signals (bandpass: 1-300 Hz) were amplified 1000-fold using an AC/DC differential amplifier (A-M Systems, Model 3000), digitized at 1 kHz with a Digidata (Molecular Devices, 1332A), and acquired using Clampex software (Molecular Devices, v10.7).</p>
<p>To assess cortical resilience in <italic>Prrt2</italic>-mutant versus wild-type mice, a stimulus-response protocol was employed using progressively increasing current intensities (0, 20, 40, 80, 120, 160, 200, 240, 280, 320 µA). Each stimulation was separated by a 24-hour interval. The stimulation threshold was defined as the lowest current intensity that induced after-discharges (lasting ≥ 2 seconds) in the EEG trace. Each EEG recording lasted for 5 minutes, with electrical stimulation delivered immediately following a 1-minute baseline period.</p>
</sec>
<sec id="s4q">
<title>Statistics</title>
<p>All grouped data are presented as mean ± standard error of mean (s.e.m) unless otherwise stated. Statistical analyses were performed using Graphpad Prism 8 (GraphPad Software Inc, La Jolla, US). No statistical methods were used to pre-determine the sample sizes. The D’Agostino-Pearson omnibus (K2) test was used to assess normality.</p>
<p>Two-tailed, unpaired Student’s <italic>t</italic>-tests were applied in <xref rid="fig1" ref-type="fig">Figures1B</xref>, <xref rid="fig7" ref-type="fig">7B</xref> and <xref rid="fig7" ref-type="fig">7D</xref>. A two-tailed, paired Student’s <italic>t</italic>-test was used in <xref rid="fig6" ref-type="fig">Figures 6D-F</xref> and supplement 4B. Two-tailed, unpaired Mann-Whitney test was applied in <xref rid="fig7" ref-type="fig">Figure 7H</xref>. Two-way ANOVAs were conducted for comparisons in <xref rid="fig1" ref-type="fig">Figures 1D</xref>, <xref rid="fig1" ref-type="fig">1F-G</xref>, <xref rid="fig2" ref-type="fig">2B-C</xref>, <xref rid="fig2" ref-type="fig">2E-F</xref>, <xref rid="fig3" ref-type="fig">3C-D</xref>, <xref rid="fig3" ref-type="fig">3F-G</xref>, <xref rid="fig4" ref-type="fig">4B-D</xref>, <xref rid="fig4" ref-type="fig">4F-H</xref>, <xref rid="fig7" ref-type="fig">7I</xref>, supplement 1B, supplement 2C-D, and supplement 3B-C. If necessary, the Gessier-Greenhouse correction was applied to adjust for violations of sphericity.</p>
<p>Statistical tests and sample sizes (including number of cells, slices, or animals) are stated in the figure legends. No data were excluded from analyses. Asterisks in figures denote significance levels: *P=&lt;=0.05, **P=&lt;=0.01, ***P=&lt;=0.001, ****P=&lt;=0.0001, n.s., not significant. Co-immunoprecipitation assays were independently repeated at least three times in both <italic>in vitro</italic> and <italic>in vivo</italic> tests. All attempts at replicating experiments presented in the manuscript have obtained consistent conclusions.</p>
<p>Electrophysiological recordings were conducted with the experimenter blinded to group identity (transfected condition or animal genotype).</p>
</sec>
</sec>
</body>
<back>
<sec id="das" sec-type="data-availability">
<title>Data availability</title>
<p>All data generated or analyzed during this study are included in the manuscript and supporting files; source data files have been provided for all figures.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>The authors thank Fei Dong, Ting-Bin Ma, Xi-Zhou, Wen-Zhang, Wei-Ke, Yue-Jie Xiao and Xue-Qin Jin for technical support for electrophysiological recording. We thank Huai-Zong Shen, Zhang-Qiang Li, Xue-Jing Li and Shu-Jia Zhu for experimental support for protein expression. We thank Tong-Zhou Li, Hong-Zhang, Jun-Jun Liu and Hai-Yan Zhen from ICE Bioscience for experimental support in sodium current recording. We appreciate the staff at the Core Facilities for their generous technical support, and members of Xiong Lab for technical support and insightful discussions.</p>
<p>This work was supported by National Natural Science Foundation of China, grants 82271269 (B.L.) and 82021001 (Z.-Q.X.); Innovation of Science and Technology 2030-Major Project “platform of nonhuman primate models”, grant 2021ZD0200900 (Z.-Q.X.); and Shanghai Municipal Science and Technology Major Project (Z.-Q.X.).</p>
</ack>
<sec id="additional-info" sec-type="additional-information">
<title>Additional information</title><sec id="s6">
<title>Materials availability</title>
<p>All plasmids and mice generated in this study are available from the lead contact with a completed materials transfer agreement.</p>
</sec>
<sec id="s8">
<title>Contributions</title>
<p>Z.-Q.X. and B.L. conceived the study and designed the experiments. B.L., Q.-W.X. and J.Z. carried out cellular and molecular experiments and data analyses. X.-M.W. and J.-Y.H. performed animal experiments and data analyses. L.Z., J.Z. and K.-X.L. are responsible for plasmids construction. G.Y. was responsible for the knock-in mice generation. Y.-X.Z. helped with animal surgery and behavior analyses. B.L. wrote the manuscript. Q.-W.X., J.Z., X.-M.W. and J.-Y.H. carried out manuscript review and editing. Z.-Q.X. and B.L. carried out project supervision, data interpretation and funding acquisition.</p>
</sec>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abramson</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Adler</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Dunger</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Evans</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Green</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Pritzel</surname>, <given-names>A.</given-names></string-name>, <etal>…</etal> <string-name><surname>Jumper</surname>, <given-names>J. M.</given-names></string-name></person-group> (<year>2024</year>). <article-title>Accurate structure prediction of biomolecular interactions with AlphaFold 3</article-title>. <source>Nature</source>, <volume>630</volume>(<issue>8016</issue>), <fpage>493</fpage>–<lpage>500</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-024-07487-w</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Armstrong</surname>, <given-names>C. M.</given-names></string-name>, &amp; <string-name><surname>Bezanilla</surname>, <given-names>F</given-names></string-name></person-group>. (<year>1977</year>). <article-title>Inactivation of the sodium channel. II. Gating current experiments</article-title>. <source>J Gen Physiol</source>, <volume>70</volume>(<issue>5</issue>), <fpage>567</fpage>–<lpage>590</lpage>. doi:<pub-id pub-id-type="doi">10.1085/jgp.70.5.567</pub-id></mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Balser</surname>, <given-names>J. R.</given-names></string-name>, <string-name><surname>Nuss</surname>, <given-names>H. B.</given-names></string-name>, <string-name><surname>Chiamvimonvat</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Perez-Garcia</surname>, <given-names>M. T.</given-names></string-name>, <string-name><surname>Marban</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name><surname>Tomaselli</surname>, <given-names>G. F</given-names></string-name></person-group>. (<year>1996</year>). <article-title>External pore residue mediates slow inactivation in mu 1 rat skeletal muscle sodium channels</article-title>. <source>J Physiol</source>, <volume>494</volume> (Pt 2)(<issue>Pt 2</issue>), <fpage>431</fpage>–<lpage>442</lpage>. doi:<pub-id pub-id-type="doi">10.1113/jphysiol.1996.sp021503</pub-id></mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bar-Yehuda</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name><surname>Korngreen</surname>, <given-names>A</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Space-clamp problems when voltage clamping neurons expressing voltage-gated conductances</article-title>. <source>J Neurophysiol</source>, <volume>99</volume>(<issue>3</issue>), <fpage>1127</fpage>–<lpage>1136</lpage>. doi:<pub-id pub-id-type="doi">10.1152/jn.01232.2007</pub-id></mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bendahhou</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Cummins</surname>, <given-names>T. R.</given-names></string-name>, <string-name><surname>Kula</surname>, <given-names>R. W.</given-names></string-name>, <string-name><surname>Fu</surname>, <given-names>Y. H.</given-names></string-name>, &amp; <string-name><surname>Ptacek</surname>, <given-names>L. J</given-names></string-name></person-group>. (<year>2002</year>). <article-title>Impairment of slow inactivation as a common mechanism for periodic paralysis in DIIS4-S5</article-title>. <source>Neurology</source>, <volume>58</volume>(<issue>8</issue>), <fpage>1266</fpage>–<lpage>1272</lpage>. doi:<pub-id pub-id-type="doi">10.1212/wnl.58.8.1266</pub-id></mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bett</surname>, <given-names>G. C.</given-names></string-name>, <string-name><surname>Dinga-Madou</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Bondarenko</surname>, <given-names>V. E.</given-names></string-name>, &amp; <string-name><surname>Rasmusson</surname>, <given-names>R. L</given-names></string-name></person-group>. (<year>2011</year>). <article-title>A model of the interaction between N-type and C-type inactivation in Kv1.4 channels</article-title>. <source>Biophys J</source>, <volume>100</volume>(<issue>1</issue>), <fpage>11</fpage>–<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bpj.2010.11.011</pub-id></mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bezanilla</surname>, <given-names>F.</given-names></string-name>, &amp; <string-name><surname>Armstrong</surname>, <given-names>C. M</given-names></string-name></person-group>. (<year>1977</year>). <article-title>Inactivation of the sodium channel. I. Sodium current experiments</article-title>. <source>J Gen Physiol</source>, <volume>70</volume>(<issue>5</issue>), <fpage>549</fpage>–<lpage>566</lpage>. doi:<pub-id pub-id-type="doi">10.1085/jgp.70.5.549</pub-id></mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Binda</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Valente</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Marte</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Baldelli</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Benfenati</surname>, <given-names>F</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Increased responsiveness at the cerebellar input stage in the PRRT2 knockout model of paroxysmal kinesigenic dyskinesia</article-title>. <source>Neurobiol Dis</source>, <volume>152</volume>, <fpage>105275</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nbd.2021.105275</pub-id></mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blume</surname>, <given-names>W. T.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>D. C.</given-names></string-name>, &amp; <string-name><surname>Pathak</surname>, <given-names>P</given-names></string-name></person-group>. (<year>2004</year>). <article-title>Properties of after-discharges from cortical electrical stimulation in focal epilepsies</article-title>. <source>Clin Neurophysiol</source>, <volume>115</volume>(<issue>4</issue>), <fpage>982</fpage>–<lpage>989</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clinph.2003.11.023</pub-id></mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cannon</surname>, <given-names>S. C</given-names></string-name></person-group>. (<year>2018</year>). <article-title>Sodium Channelopathies of Skeletal Muscle</article-title>. <source>Handb Exp Pharmacol</source>, <volume>246</volume>, <fpage>309</fpage>–<lpage>330</lpage>. doi:<pub-id pub-id-type="doi">10.1007/164_2017_52</pub-id></mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Catterall</surname>, <given-names>W. A</given-names></string-name></person-group>. (<year>2023</year>). <article-title>Voltage gated sodium and calcium channels: Discovery, structure, function, and Pharmacology</article-title>. <source>Channels (Austin)</source>, <volume>17</volume>(<issue>1</issue>), <fpage>2281714</fpage>. doi:<pub-id pub-id-type="doi">10.1080/19336950.2023.2281714</pub-id></mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Catterall</surname>, <given-names>W. A.</given-names></string-name>, <string-name><surname>Goldin</surname>, <given-names>A. L.</given-names></string-name>, &amp; <string-name><surname>Waxman</surname>, <given-names>S. G</given-names></string-name></person-group>. (<year>2005</year>). <article-title>International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels</article-title>. <source>Pharmacol Rev</source>, <volume>57</volume>(<issue>4</issue>), <fpage>397</fpage>–<lpage>409</lpage>. doi:<pub-id pub-id-type="doi">10.1124/pr.57.4.4</pub-id></mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Catterall</surname>, <given-names>W. A.</given-names></string-name>, <string-name><surname>Wisedchaisri</surname>, <given-names>G.</given-names></string-name>, &amp; <string-name><surname>Zheng</surname>, <given-names>N</given-names></string-name></person-group>. (<year>2020</year>). <article-title>The conformational cycle of a prototypical voltage-gated sodium channel</article-title>. <source>Nat Chem Biol</source>, <volume>16</volume>(<issue>12</issue>), <fpage>1314</fpage>–<lpage>1320</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41589-020-0644-4</pub-id></mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chancey</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Shockett</surname>, <given-names>P. E.</given-names></string-name>, &amp; <string-name><surname>O’Reilly</surname>, <given-names>J. P</given-names></string-name></person-group>. (<year>2007</year>). <article-title>Relative resistance to slow inactivation of human cardiac Na+ channel hNav1.5 is reversed by lysine or glutamine substitution at V930 in D2-S6</article-title>. <source>Am J Physiol Cell Physiol</source>, <volume>293</volume>(<issue>6</issue>), <fpage>C1895</fpage>–<lpage>1905</lpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpcell.00377.2007</pub-id></mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chatterjee</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Vyas</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Chalamalasetti</surname>, <given-names>S. V.</given-names></string-name>, <string-name><surname>Sahu</surname>, <given-names>I. D.</given-names></string-name>, <string-name><surname>Clatot</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wan</surname>, <given-names>X.</given-names></string-name>, <etal>…</etal> <string-name><surname>Chakrapani</surname>, <given-names>S.</given-names></string-name></person-group> (<year>2018</year>). <article-title>The voltage-gated sodium channel pore exhibits conformational flexibility during slow inactivation</article-title>. <source>J Gen Physiol</source>, <volume>150</volume>(<issue>9</issue>), <fpage>1333</fpage>–<lpage>1347</lpage>. doi:<pub-id pub-id-type="doi">10.1085/jgp.201812118</pub-id></mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>, <given-names>W. J.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Xiong</surname>, <given-names>Z. Q.</given-names></string-name>, <string-name><surname>Wei</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Ni</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Tan</surname>, <given-names>G. H.</given-names></string-name>, <etal>…</etal> <string-name><surname>Wu</surname>, <given-names>Z. Y</given-names></string-name></person-group>. (<year>2011</year>). <article-title>Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia</article-title>. <source>Nat Genet</source>, <volume>43</volume>(<issue>12</issue>), <fpage>1252</fpage>–<lpage>1255</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.1008</pub-id></mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>F. H.</given-names></string-name>, <string-name><surname>Surmeier</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Scheuer</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name><surname>Catterall</surname>, <given-names>W. A</given-names></string-name></person-group>. (<year>2006</year>). <article-title>Neuromodulation of Na+ channel slow inactivation via cAMP-dependent protein kinase and protein kinase C</article-title>. <source>Neuron</source>, <volume>49</volume>(<issue>3</issue>), <fpage>409</fpage>–<lpage>420</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuron.2006.01.009</pub-id></mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cummins</surname>, <given-names>T. R.</given-names></string-name>, &amp; <string-name><surname>Sigworth</surname>, <given-names>F. J</given-names></string-name></person-group>. (<year>1996</year>). <article-title>Impaired slow inactivation in mutant sodium channels</article-title>. <source>Biophys J</source>, <volume>71</volume>(<issue>1</issue>), <fpage>227</fpage>–<lpage>236</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0006-3495(96)79219-6</pub-id></mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cusdin</surname>, <given-names>F. S.</given-names></string-name>, <string-name><surname>Clare</surname>, <given-names>J. J.</given-names></string-name>, &amp; <string-name><surname>Jackson</surname>, <given-names>A. P</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Trafficking and cellular distribution of voltage-gated sodium channels</article-title>. <source>Traffic</source>, <volume>9</volume>(<issue>1</issue>), <fpage>17</fpage>–<lpage>26</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1600-0854.2007.00673.x</pub-id></mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dib-Hajj</surname>, <given-names>S. D.</given-names></string-name>, <string-name><surname>Geha</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Waxman</surname>, <given-names>S. G</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Sodium channels in pain disorders: pathophysiology and prospects for treatment</article-title>. <source>Pain</source>, <volume>158</volume> <issue>Suppl 1</issue>, <fpage>S97</fpage>–<lpage>S107</lpage>. doi:<pub-id pub-id-type="doi">10.1097/j.pain.0000000000000854</pub-id></mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dover</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Solinas</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>D’Angelo</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name><surname>Goldfarb</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Long-term inactivation particle for voltagegated sodium channels</article-title>. <source>J Physiol</source>, <volume>588</volume>(<issue>Pt 19</issue>), <fpage>3695</fpage>–<lpage>3711</lpage>. doi:<pub-id pub-id-type="doi">10.1113/jphysiol.2010.192559</pub-id></mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ehrlich</surname>, <given-names>K. C.</given-names></string-name>, <string-name><surname>Lacey</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Ehrlich</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2020</year>). <article-title>Epigenetics of Skeletal Muscle-Associated Genes in the ASB, LRRC, TMEM, and OSBPL Gene Families</article-title>. <source>Epigenomes</source>, <volume>4</volume>(<issue>1</issue>). doi:<pub-id pub-id-type="doi">10.3390/epigenomes4010001</pub-id></mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Escayg</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Goldin</surname>, <given-names>A. L</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Sodium channel SCN1A and epilepsy: mutations and mechanisms</article-title>. <source>Epilepsia</source>, <volume>51</volume>(<issue>9</issue>), <fpage>1650</fpage>–<lpage>1658</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2010.02640.x</pub-id></mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Featherstone</surname>, <given-names>D. E.</given-names></string-name>, <string-name><surname>Richmond</surname>, <given-names>J. E.</given-names></string-name>, &amp; <string-name><surname>Ruben</surname>, <given-names>P. C</given-names></string-name></person-group>. (<year>1996</year>). <article-title>Interaction between fast and slow inactivation in Skm1 sodium channels</article-title>. <source>Biophys J</source>, <volume>71</volume>(<issue>6</issue>), <fpage>3098</fpage>–<lpage>3109</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0006-3495(96)79504-8</pub-id></mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Franchi</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Marte</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Corradi</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Sterlini</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Alberini</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Romei</surname>, <given-names>A.</given-names></string-name>, <etal>…</etal> <string-name><surname>Benfenati</surname>, <given-names>F.</given-names></string-name></person-group> (<year>2023</year>). <article-title>The intramembrane COOH-terminal domain of PRRT2 regulates voltage-dependent Na(+) channels</article-title>. <source>J Biol Chem</source>, <fpage>104632</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jbc.2023.104632</pub-id></mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fruscione</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Valente</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Sterlini</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Romei</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Baldassari</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Fadda</surname>, <given-names>M.</given-names></string-name>, <etal>…</etal> <string-name><surname>Benfenati</surname>, <given-names>F.</given-names></string-name></person-group> (<year>2018</year>). <article-title>PRRT2 controls neuronal excitability by negatively modulating Na channel 1.2/1.6 activity</article-title>. <source>Brain</source>, <volume>141</volume>(<issue>4</issue>), <fpage>1000</fpage>–<lpage>1016</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awy051</pub-id></mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gade</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Marx</surname>, <given-names>S. O.</given-names></string-name>, &amp; <string-name><surname>Pitt</surname>, <given-names>G. S</given-names></string-name></person-group>. (<year>2020</year>). <article-title>An interaction between the III-IV linker and CTD in NaV1.5 confers regulation of inactivation by CaM and FHF</article-title>. <source>J Gen Physiol</source>, <volume>152</volume>(<issue>2</issue>). doi:<pub-id pub-id-type="doi">10.1085/jgp.201912434</pub-id></mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ganguly</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Thompson</surname>, <given-names>C. H.</given-names></string-name>, &amp; <string-name><surname>George</surname>, <given-names>A. L.</given-names>, <suffix>Jr</suffix></string-name></person-group>. (<year>2021</year>). <article-title>Enhanced slow inactivation contributes to dysfunction of a recurrent SCN2A mutation associated with developmental and epileptic encephalopathy</article-title>. <source>J Physiol</source>, <volume>599</volume>(<issue>18</issue>), <fpage>4375</fpage>–<lpage>4388</lpage>. doi:<pub-id pub-id-type="doi">10.1113/JP281834</pub-id></mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ghovanloo</surname>, <given-names>M. R.</given-names></string-name>, <string-name><surname>Effraim</surname>, <given-names>P. R.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Schulman</surname>, <given-names>B. R.</given-names></string-name>, <string-name><surname>Jacobs</surname>, <given-names>D. S.</given-names></string-name>, <string-name><surname>Dib-Hajj</surname>, <given-names>S. D.</given-names></string-name>, &amp; <string-name><surname>Waxman</surname>, <given-names>S. G</given-names></string-name></person-group>. (<year>2023</year>). <article-title>Nav1.7 P610T mutation in two siblings with persistent ocular pain after corneal axon transection: impaired slow inactivation and hyperexcitable trigeminal neurons</article-title>. <source>J Neurophysiol</source>, <volume>129</volume>(<issue>3</issue>), <fpage>609</fpage>–<lpage>618</lpage>. doi:<pub-id pub-id-type="doi">10.1152/jn.00457.2022</pub-id></mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goetz</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Dover</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Laezza</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Shtraizent</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Tchetchik</surname>, <given-names>D.</given-names></string-name>, <etal>…</etal> <string-name><surname>Mohammadi</surname>, <given-names>M.</given-names></string-name></person-group> (<year>2009</year>). <article-title>Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels</article-title>. <source>J Biol Chem</source>, <volume>284</volume>(<issue>26</issue>), <fpage>17883</fpage>–<lpage>17896</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M109.001842</pub-id></mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goldin</surname>, <given-names>A. L</given-names></string-name></person-group>. (<year>2001</year>). <article-title>Resurgence of sodium channel research</article-title>. <source>Annu Rev Physiol</source>, <volume>63</volume>, <fpage>871</fpage>–<lpage>894</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.physiol.63.1.871</pub-id></mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goldin</surname>, <given-names>A. L</given-names></string-name></person-group>. (<year>2003</year>). <article-title>Mechanisms of sodium channel inactivation</article-title>. <source>Curr Opin Neurobiol</source>, <volume>13</volume>(<issue>3</issue>), <fpage>284</fpage>–<lpage>290</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0959-4388(03)00065-5</pub-id></mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hayward</surname>, <given-names>L. J.</given-names></string-name>, <string-name><surname>Sandoval</surname>, <given-names>G. M.</given-names></string-name>, &amp; <string-name><surname>Cannon</surname>, <given-names>S. C</given-names></string-name></person-group>. (<year>1999</year>). <article-title>Defective slow inactivation of sodium channels contributes to familial periodic paralysis</article-title>. <source>Neurology</source>, <volume>52</volume>(<issue>7</issue>), <fpage>1447</fpage>–<lpage>1453</lpage>. doi:<pub-id pub-id-type="doi">10.1212/wnl.52.7.1447</pub-id></mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname>, <given-names>B.</given-names></string-name>, &amp; <string-name><surname>Soderlund</surname>, <given-names>D. M</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Functional expression of Rat Nav1.6 voltage-gated sodium channels in HEK293 cells: modulation by the auxiliary beta1 subunit</article-title>. <source>PLoS One</source>, <volume>9</volume>(<issue>1</issue>), <fpage>e85188</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0085188</pub-id></mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hedrich</surname>, <given-names>U. B. S.</given-names></string-name>, <string-name><surname>Lauxmann</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Lerche</surname>, <given-names>H</given-names></string-name></person-group>. (<year>2019</year>). <article-title>SCN2A channelopathies: Mechanisms and models</article-title>. <source>Epilepsia</source>, <volume>60</volume> <issue>Suppl 3</issue>, <fpage>S68</fpage>–<lpage>S76</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.14731</pub-id></mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hodgkin</surname>, <given-names>A. L.</given-names></string-name>, &amp; <string-name><surname>Huxley</surname>, <given-names>A. F</given-names></string-name></person-group>. (<year>1952</year>). <article-title>A quantitative description of membrane current and its application to conduction and excitation in nerve</article-title>. <source>J Physiol</source>, <volume>117</volume>(<issue>4</issue>), <fpage>500</fpage>–<lpage>544</lpage>. doi:<pub-id pub-id-type="doi">10.1113/jphysiol.1952.sp004764</pub-id></mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoshi</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Zagotta</surname>, <given-names>W. N.</given-names></string-name>, &amp; <string-name><surname>Aldrich</surname>, <given-names>R. W</given-names></string-name></person-group>. (<year>1990</year>). <article-title>Biophysical and molecular mechanisms of Shaker potassium channel inactivation</article-title>. <source>Science</source>, <volume>250</volume>(<issue>4980</issue>), <fpage>533</fpage>–<lpage>538</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.2122519</pub-id></mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname>, <given-names>W.</given-names></string-name>, &amp; <string-name><surname>Shu</surname>, <given-names>Y</given-names></string-name></person-group>. (<year>2012</year>). <article-title>Axonal bleb recording</article-title>. <source>Neurosci Bull</source>, <volume>28</volume>(<issue>4</issue>), <fpage>342</fpage>–<lpage>350</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12264-012-1247-1</pub-id></mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Isom</surname>, <given-names>L. L.</given-names></string-name>, <string-name><surname>De Jongh</surname>, <given-names>K. S.</given-names></string-name>, <string-name><surname>Patton</surname>, <given-names>D. E.</given-names></string-name>, <string-name><surname>Reber</surname>, <given-names>B. F.</given-names></string-name>, <string-name><surname>Offord</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Charbonneau</surname>, <given-names>H.</given-names></string-name>, <etal>…</etal> <string-name><surname>Catterall</surname>, <given-names>W. A.</given-names></string-name></person-group> (<year>1992</year>). <article-title>Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel</article-title>. <source>Science</source>, <volume>256</volume>(<issue>5058</issue>), <fpage>839</fpage>–<lpage>842</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1375395</pub-id></mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Tonggu</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Gamal El-Din</surname>, <given-names>T. M.</given-names></string-name>, <string-name><surname>Lenaeus</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>Y.</given-names></string-name>, <etal>…</etal> <string-name><surname>Catterall</surname>, <given-names>W. A.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Structure of the Cardiac Sodium Channel</article-title>. <source>Cell</source>, <volume>180</volume>(<issue>1</issue>), <fpage>122</fpage>–<lpage>134.e110.</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.cell.2019.11.041</pub-id></mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>, <given-names>H. Y.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Bruneau</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Roll</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Roberson</surname>, <given-names>E. D.</given-names></string-name>, <string-name><surname>Hermann</surname>, <given-names>M.</given-names></string-name>, <etal>…</etal> <string-name><surname>Ptacek</surname>, <given-names>L. J.</given-names></string-name></person-group> (<year>2012</year>). <article-title>Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions</article-title>. <source>Cell Rep</source>, <volume>1</volume>(<issue>1</issue>), <fpage>2</fpage>–<lpage>12</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2011.11.001</pub-id></mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Lou</surname>, <given-names>S. S.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>R. S.</given-names></string-name>, <string-name><surname>Kong</surname>, <given-names>D. L.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>R. J.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>J.</given-names></string-name>, <etal>…</etal> <string-name><surname>Xiong</surname>, <given-names>Z. Q.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Cerebellar spreading depolarization mediates paroxysmal movement disorder</article-title>. <source>Cell Rep</source>, <volume>36</volume>(<issue>12</issue>), <fpage>109743</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2021.109743</pub-id></mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Makita</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Bennett</surname>, <given-names>P. B.</given-names></string-name>, &amp; <string-name><surname>George</surname>, <given-names>A. L.</given-names>, <suffix>Jr</suffix></string-name></person-group>. (<year>1996</year>). <article-title>Molecular determinants of beta 1 subunit-induced gating modulation in voltage-dependent Na+ channels</article-title>. <source>J Neurosci</source>, <volume>16</volume>(<issue>22</issue>), <fpage>7117</fpage>–<lpage>7127</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-22-07117.1996</pub-id></mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mantegazza</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Cestele</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Catterall</surname>, <given-names>W. A</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Sodium channelopathies of skeletal muscle and brain</article-title>. <source>Physiol Rev</source>, <volume>101</volume>(<issue>4</issue>), <fpage>1633</fpage>–<lpage>1689</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.00025.2020</pub-id></mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matsuda</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name><surname>Cepko</surname>, <given-names>C. L</given-names></string-name></person-group>. (<year>2004</year>). <article-title>Electroporation and RNA interference in the rodent retina in vivo and in vitro</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>101</volume>(<issue>1</issue>), <fpage>16</fpage>–<lpage>22</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.2235688100</pub-id></mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meisler</surname>, <given-names>M. H.</given-names></string-name>, <string-name><surname>Hill</surname>, <given-names>S. F.</given-names></string-name>, &amp; <string-name><surname>Yu</surname>, <given-names>W</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Sodium channelopathies in neurodevelopmental disorders</article-title>. <source>Nat Rev Neurosci</source>, <volume>22</volume>(<issue>3</issue>), <fpage>152</fpage>–<lpage>166</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41583-020-00418-4</pub-id></mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Misra</surname>, <given-names>S. N.</given-names></string-name>, <string-name><surname>Kahlig</surname>, <given-names>K. M.</given-names></string-name>, &amp; <string-name><surname>George</surname>, <given-names>A. L.</given-names>, <suffix>Jr</suffix></string-name></person-group>. (<year>2008</year>). <article-title>Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures</article-title>. <source>Epilepsia</source>, <volume>49</volume>(<issue>9</issue>), <fpage>1535</fpage>–<lpage>1545</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01619.x</pub-id></mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mitrovic</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>A. L.</given-names>, <suffix>Jr.</suffix></string-name>, &amp; <string-name><surname>Horn</surname>, <given-names>R</given-names></string-name></person-group>. (<year>2000</year>). <article-title>Role of domain 4 in sodium channel slow inactivation</article-title>. <source>J Gen Physiol</source>, <volume>115</volume>(<issue>6</issue>), <fpage>707</fpage>–<lpage>718</lpage>. doi:<pub-id pub-id-type="doi">10.1085/jgp.115.6.707</pub-id></mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Noreng</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name><surname>Payandeh</surname>, <given-names>J</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Structural Pharmacology of Voltage-Gated Sodium Channels</article-title>. <source>J Mol Biol</source>, <volume>433</volume>(<issue>17</issue>), <fpage>166967</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jmb.2021.166967</pub-id></mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Olsen</surname>, <given-names>S. K.</given-names></string-name>, <string-name><surname>Garbi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zampieri</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Eliseenkova</surname>, <given-names>A. V.</given-names></string-name>, <string-name><surname>Ornitz</surname>, <given-names>D. M.</given-names></string-name>, <string-name><surname>Goldfarb</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Mohammadi</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2003</year>). <article-title>Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs</article-title>. <source>J Biol Chem</source>, <volume>278</volume>(<issue>36</issue>), <fpage>34226</fpage>–<lpage>34236</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M303183200</pub-id></mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Oort</surname>, <given-names>P. J.</given-names></string-name>, <string-name><surname>Warden</surname>, <given-names>C. H.</given-names></string-name>, <string-name><surname>Baumann</surname>, <given-names>T. K.</given-names></string-name>, <string-name><surname>Knotts</surname>, <given-names>T. A.</given-names></string-name>, &amp; <string-name><surname>Adams</surname>, <given-names>S. H</given-names></string-name></person-group>. (<year>2007</year>). <article-title>Characterization of Tusc5, an adipocyte gene co-expressed in peripheral neurons</article-title>. <source>Mol Cell Endocrinol</source>, <volume>276</volume>(<issue>1-2</issue>), <fpage>24</fpage>–<lpage>35</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mce.2007.06.005</pub-id></mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pan</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>H.</given-names></string-name>, <etal>…</etal> <string-name><surname>Yan</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Molecular basis for pore blockade of human Na(+) channel Na(v)1.2 by the mu-conotoxin KIIIA</article-title>. <source>Science</source>, <volume>363</volume>(<issue>6433</issue>), <fpage>1309</fpage>–<lpage>1313</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aaw2999</pub-id></mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pan</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Jin</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>X.</given-names></string-name>, <etal>…</etal> <string-name><surname>Yan</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Comparative structural analysis of human Na(v)1.1 and Na(v)1.5 reveals mutational hotspots for sodium channelopathies</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>118</volume>(<issue>11</issue>). doi:<pub-id pub-id-type="doi">10.1073/pnas.2100066118</pub-id></mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Payandeh</surname>, <given-names>J</given-names></string-name></person-group>. (<year>2018</year>). <article-title>Progress in understanding slow inactivation speeds up</article-title>. <source>J Gen Physiol</source>, <volume>150</volume>(<issue>9</issue>), <fpage>1235</fpage>–<lpage>1238</lpage>. doi:<pub-id pub-id-type="doi">10.1085/jgp.201812149</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Remme</surname>, <given-names>C. A</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects</article-title>. <source>J Physiol</source>, <volume>591</volume>(<issue>17</issue>), <fpage>4099</fpage>–<lpage>4116</lpage>. doi:<pub-id pub-id-type="doi">10.1113/jphysiol.2013.256461</pub-id></mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Riant</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Roos</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Roubertie</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Barbance</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Hadjadj</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Auvin</surname>, <given-names>S.</given-names></string-name>, <etal>…</etal> <string-name><surname>Ducros</surname>, <given-names>A.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Hemiplegic Migraine Associated With PRRT2 Variations: A Clinical and Genetic Study</article-title>. <source>Neurology</source>, <volume>98</volume>(<issue>1</issue>), <fpage>e51</fpage>–<lpage>e61</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000012947</pub-id></mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Richmond</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Featherstone</surname>, <given-names>D. E.</given-names></string-name>, <string-name><surname>Hartmann</surname>, <given-names>H. A.</given-names></string-name>, &amp; <string-name><surname>Ruben</surname>, <given-names>P. C</given-names></string-name></person-group>. (<year>1998</year>). <article-title>Slow inactivation in human cardiac sodium channels</article-title>. <source>Biophys J</source>, <volume>74</volume>(<issue>6</issue>), <fpage>2945</fpage>–<lpage>2952</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0006-3495(98)78001-4</pub-id></mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rudy</surname>, <given-names>B</given-names></string-name></person-group>. (<year>1978</year>). <article-title>Slow inactivation of the sodium conductance in squid giant axons. Pronase resistance</article-title>. <source>J Physiol</source>, <volume>283</volume>, <fpage>1</fpage>–<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1113/jphysiol.1978.sp012485</pub-id></mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sallman Almen</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bringeland</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Fredriksson</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Schioth</surname>, <given-names>H. B.</given-names></string-name></person-group> (<year>2012</year>). <article-title>The dispanins: a novel gene family of ancient origin that contains 14 human members</article-title>. <source>PLoS One</source>, <volume>7</volume>(<issue>2</issue>), <fpage>e31961</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0031961</pub-id></mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Santana-Varela</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Bogdanov</surname>, <given-names>Y. D.</given-names></string-name>, <string-name><surname>Gossage</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Okorokov</surname>, <given-names>A. L.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>de Clauser</surname>, <given-names>L.</given-names></string-name>, <etal>…</etal> <string-name><surname>Cox</surname>, <given-names>J. J.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Tools for analysis and conditional deletion of subsets of sensory neurons</article-title>. <source>Wellcome Open Res</source>, <volume>6</volume>, <fpage>250</fpage>. doi:<pub-id pub-id-type="doi">10.12688/wellcomeopenres.17090.1</pub-id></mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shibata</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Koide</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Hayashi</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Nagata</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Takeo</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Yoshida</surname>, <given-names>T.</given-names></string-name>, <etal>…</etal> <string-name><surname>Tatsuno</surname>, <given-names>I.</given-names></string-name></person-group> (<year>2007</year>). <article-title>Molecular cloning and characterization of rat brain endothelial cell derived gene-1 (tumor suppressor candidate 5) expressing abundantly in adipose tissues</article-title>. <source>Mol Cell Endocrinol</source>, <volume>263</volume>(<issue>1-2</issue>), <fpage>38</fpage>–<lpage>45</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mce.2006.08.007</pub-id></mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Silva</surname>, <given-names>J</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Slow inactivation of Na(+) channels</article-title>. <source>Handb Exp Pharmacol</source>, <volume>221</volume>, <fpage>33</fpage>–<lpage>49</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-3-642-41588-3_3</pub-id></mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname>, <given-names>G. H.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>Y. Y.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Z. Q.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>H. F.</given-names></string-name>, <etal>…</etal> <string-name><surname>Xiong</surname>, <given-names>Z. Q.</given-names></string-name></person-group> (<year>2018</year>). <article-title>PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by regulating synaptic transmission in cerebellum</article-title>. <source>Cell Res</source>, <volume>28</volume>(<issue>1</issue>), <fpage>90</fpage>–<lpage>110</lpage>. doi:<pub-id pub-id-type="doi">10.1038/cr.2017.128</pub-id></mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thompson</surname>, <given-names>C. H.</given-names></string-name>, <string-name><surname>Potet</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Abramova</surname>, <given-names>T. V.</given-names></string-name>, <string-name><surname>DeKeyser</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Ghabra</surname>, <given-names>N. F.</given-names></string-name>, <string-name><surname>Vanoye</surname>, <given-names>C. G.</given-names></string-name>, <etal>…</etal> <string-name><surname>George</surname>, <given-names>A. L.</given-names></string-name></person-group> (<year>2023</year>). <article-title>Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties</article-title>. <source>J Gen Physiol</source>, <volume>155</volume>(<issue>10</issue>):<elocation-id>e202313375</elocation-id>. doi:<pub-id pub-id-type="doi">10.1085/jgp.202313375</pub-id></mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Todt</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Dudley</surname>, <given-names>S. C.</given-names>, <suffix>Jr.</suffix></string-name>, <string-name><surname>Kyle</surname>, <given-names>J. W.</given-names></string-name>, <string-name><surname>French</surname>, <given-names>R. J.</given-names></string-name>, &amp; <string-name><surname>Fozzard</surname>, <given-names>H. A</given-names></string-name></person-group>. (<year>1999</year>). <article-title>Ultra-slow inactivation in mu1 Na+ channels is produced by a structural rearrangement of the outer vestibule</article-title>. <source>Biophys J</source>, <volume>76</volume>(<issue>3</issue>), <fpage>1335</fpage>–<lpage>1345</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0006-3495(99)77296-6</pub-id></mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ulbricht</surname>, <given-names>W</given-names></string-name></person-group>. (<year>1977</year>). <article-title>Ionic channels and gating currents in excitable membranes</article-title>. <source>Annu Rev Biophys Bioeng</source>, <volume>6</volume>, <fpage>7</fpage>–<lpage>31</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.bb.06.060177.000255</pub-id></mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Valente</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Marte</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Franchi</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Sterlini</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Casagrande</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Corradi</surname>, <given-names>A.</given-names></string-name>, <etal>…</etal> <string-name><surname>Benfenati</surname>, <given-names>F.</given-names></string-name></person-group> (<year>2023</year>). <article-title>A Push-Pull Mechanism Between PRRT2 and beta4-subunit Differentially Regulates Membrane Exposure and Biophysical Properties of NaV1.2 Sodium Channels</article-title>. <source>Mol Neurobiol</source>, <volume>60</volume>(<issue>3</issue>), <fpage>1281</fpage>–<lpage>1296</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12035-022-03112-x</pub-id></mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Venkatesan</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>Y.</given-names></string-name>, &amp; <string-name><surname>Goldfarb</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Fast-onset long-term open-state block of sodium channels by A-type FHFs mediates classical spike accommodation in hippocampal pyramidal neurons</article-title>. <source>J Neurosci</source>, <volume>34</volume>(<issue>48</issue>), <fpage>16126</fpage>–<lpage>16139</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1271-14.2014</pub-id></mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vilin</surname>, <given-names>Y. Y.</given-names></string-name>, <string-name><surname>Makita</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>A. L.</given-names>, <suffix>Jr.</suffix></string-name>, &amp; <string-name><surname>Ruben</surname>, <given-names>P. C</given-names></string-name></person-group>. (<year>1999</year>). <article-title>Structural determinants of slow inactivation in human cardiac and skeletal muscle sodium channels</article-title>. <source>Biophys J</source>, <volume>77</volume>(<issue>3</issue>), <fpage>1384</fpage>–<lpage>1393</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0006-3495(99)76987-0</pub-id></mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vilin</surname>, <given-names>Y. Y.</given-names></string-name>, &amp; <string-name><surname>Ruben</surname>, <given-names>P. C</given-names></string-name></person-group>. (<year>2001</year>). <article-title>Slow inactivation in voltage-gated sodium channels: molecular substrates and contributions to channelopathies</article-title>. <source>Cell Biochem Biophys</source>, <volume>35</volume>(<issue>2</issue>), <fpage>171</fpage>–<lpage>190</lpage>. doi:<pub-id pub-id-type="doi">10.1385/CBB:35:2:171</pub-id></mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wallner</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Weigl</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Meera</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Lotan</surname>, <given-names>I</given-names></string-name></person-group>. (<year>1993</year>). <article-title>Modulation of the skeletal muscle sodium channel alpha-subunit by the beta 1-subunit</article-title>. <source>FEBS Lett</source>, <volume>336</volume>(<issue>3</issue>), <fpage>535</fpage>–<lpage>539</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0014-5793(93)80871-q</pub-id></mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>D. W.</given-names></string-name>, <string-name><surname>Makita</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Kitabatake</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Balser</surname>, <given-names>J. R.</given-names></string-name>, &amp; <string-name><surname>George</surname>, <given-names>A. L.</given-names>, <suffix>Jr</suffix></string-name></person-group>. (<year>2000</year>). <article-title>Enhanced Na(+) channel intermediate inactivation in Brugada syndrome</article-title>. <source>Circ Res</source>, <volume>87</volume>(<issue>8</issue>), <fpage>E37</fpage>–<lpage>43</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.res.87.8.e37</pub-id></mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Cao</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X. H.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>Z. M.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>J. G.</given-names></string-name>, <etal>…</etal> <string-name><surname>Tang</surname>, <given-names>B. S.</given-names></string-name></person-group> (<year>2011</year>). <article-title>Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias</article-title>. <source>Brain</source>, <volume>134</volume>(<issue>Pt 12</issue>), <fpage>3493</fpage>–<lpage>3501</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awr289</pub-id></mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>S. Y.</given-names></string-name>, &amp; <string-name><surname>Wang</surname>, <given-names>G. K</given-names></string-name></person-group>. (<year>1997</year>). <article-title>A mutation in segment I-S6 alters slow inactivation of sodium channels</article-title>. <source>Biophys J</source>, <volume>72</volume>(<issue>4</issue>), <fpage>1633</fpage>–<lpage>1640</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0006-3495(97)78809-X</pub-id></mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Waxman</surname>, <given-names>S. G</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Painful Na-channelopathies: an expanding universe</article-title>. <source>Trends Mol Med</source>, <volume>19</volume>(<issue>7</issue>), <fpage>406</fpage>–<lpage>409</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molmed.2013.04.003</pub-id></mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Webb</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>F. F.</given-names></string-name>, &amp; <string-name><surname>Cannon</surname>, <given-names>S. C</given-names></string-name></person-group>. (<year>2009</year>). <article-title>Slow inactivation of the NaV1.4 sodium channel in mammalian cells is impeded by co-expression of the beta1 subunit</article-title>. <source>Pflugers Arch</source>, <volume>457</volume>(<issue>6</issue>), <fpage>1253</fpage>–<lpage>1263</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00424-008-0600-8</pub-id></mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wisedchaisri</surname>, <given-names>G.</given-names></string-name>, &amp; <string-name><surname>Gamal El-Din</surname>, <given-names>T. M</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Druggability of Voltage-Gated Sodium Channels-Exploring Old and New Drug Receptor Sites</article-title>. <source>Front Pharmacol</source>, <volume>13</volume>, <fpage>858348</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphar.2022.858348</pub-id></mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiong</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Farukhi</surname>, <given-names>Y. Z.</given-names></string-name>, <string-name><surname>Tian</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Disilvestre</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>R. A.</given-names></string-name>, &amp; <string-name><surname>Tomaselli</surname>, <given-names>G. F</given-names></string-name></person-group>. (<year>2006</year>). <article-title>A conserved ring of charge in mammalian Na+ channels: a molecular regulator of the outer pore conformation during slow inactivation</article-title>. <source>J Physiol</source>, <volume>576</volume>(<issue>Pt 3</issue>), <fpage>739</fpage>–<lpage>754</lpage>. doi:<pub-id pub-id-type="doi">10.1113/jphysiol.2006.115105</pub-id></mixed-citation></ref>
<ref id="c79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Thomas</surname>, <given-names>E. A.</given-names></string-name>, <string-name><surname>Gazina</surname>, <given-names>E. V.</given-names></string-name>, <string-name><surname>Richards</surname>, <given-names>K. L.</given-names></string-name>, <string-name><surname>Quick</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Wallace</surname>, <given-names>R. H.</given-names></string-name>, <etal>…</etal> <string-name><surname>Petrou</surname>, <given-names>S.</given-names></string-name></person-group> (<year>2007</year>). <article-title>Generalized epilepsy with febrile seizures plus-associated sodium channel beta1 subunit mutations severely reduce beta subunit-mediated modulation of sodium channel function</article-title>. <source>Neuroscience</source>, <volume>148</volume>(<issue>1</issue>), <fpage>164</fpage>–<lpage>174</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.05.038</pub-id></mixed-citation></ref>
<ref id="c80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yamano</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Miyazaki</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Nukina</surname>, <given-names>N</given-names></string-name></person-group>. (<year>2022</year>). <article-title>The diffuse distribution of Nav1.2 on mid-axonal regions is a marker for unmyelinated fibers in the central nervous system</article-title>. <source>Neurosci Res</source>, <volume>177</volume>, <fpage>145</fpage>–<lpage>150</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neures.2021.11.005</pub-id></mixed-citation></ref>
<ref id="c81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Jaenisch</surname>, <given-names>R</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Generating genetically modified mice using CRISPR/Cas-mediated genome engineering</article-title>. <source>Nat Protoc</source>, <volume>9</volume>(<issue>8</issue>), <fpage>1956</fpage>–<lpage>1968</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nprot.2014.134</pub-id></mixed-citation></ref>
<ref id="c82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname>, <given-names>F. H.</given-names></string-name>, <string-name><surname>Mantegazza</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Westenbroek</surname>, <given-names>R. E.</given-names></string-name>, <string-name><surname>Robbins</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Kalume</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Burton</surname>, <given-names>K. A.</given-names></string-name>, <etal>…</etal> <string-name><surname>Catterall</surname>, <given-names>W. A.</given-names></string-name></person-group> (<year>2006</year>). <article-title>Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy</article-title>. <source>Nat Neurosci</source>, <volume>9</volume>(<issue>9</issue>), <fpage>1142</fpage>–<lpage>1149</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nn1754</pub-id></mixed-citation></ref>
<ref id="c83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Marder</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name><surname>Marom</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2023</year>). <article-title>Sodium channel slow inactivation normalizes firing in axons with uneven conductance distributions</article-title>. <source>Curr Biol</source>, <volume>33</volume>(<issue>9</issue>), <fpage>1818</fpage>–<lpage>1824.e1813.</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.cub.2023.03.043</pub-id></mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109327.1.sa4</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Griffith</surname>
<given-names>Theanne N</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/05rrcem69</institution-id><institution>University of California, Davis</institution>
</institution-wrap>
<city>Davis</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Compelling</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>important</bold> study identifies PRRT2 as an auxiliary regulator of Nav channel slow inactivation, proposing that PRRT2 facilitates entry into, and delays recovery from, the slow-inactivated state. The evidence provided is <bold>compelling</bold> and well executed, though the work would be bolstered by additional studies of Nav1.6, as well as structural studies to directly investigate the molecular basis of gating modulation. Overall, this study will be of interest to ion channel biophysicists and neurophysiologists, particularly those studying channelopathies.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109327.1.sa3</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The manuscript by Lu and colleagues demonstrates convincingly that PRRT2 interacts with brain voltage-gated sodium channels to enhance slow inactivation in vitro and in vivo. The work is interesting and rigorously conducted. The relevance to normal physiology and disease pathophysiology (e.g., PRRT2-related genetic neurodevelopmental disorders) seems high. Some simple additional experiments could elevate the impact and make the study more complete.</p>
<p>Strengths:</p>
<p>Experiments are conducted rigorously, including experimenter blinding and appropriate controls. Data presentation is excellent and logical. The paper is well written for a general scientific audience.</p>
<p>Weaknesses:</p>
<p>There are a few missing experiments and one place where data are over-interpreted.</p>
<p>(1) An in vitro study of Nav1.6 is conspicuously absent. In addition to being a major brain Na channel, Nav1.6 is predominant in cerebellar Purkinje neurons, which the authors note lack PRRT2 expression. They speculate that the absence of PRRT2 in these neurons facilitates the high firing rate. This hypothesis would be strengthened if PRRT2 also enhanced slow inactivation of Nav1.6. If a stable Nav1.6 cell were not available, then simple transient co-transfection experiments would suffice.</p>
<p>(2) To further demonstrate the physiological impact of enhanced slow inactivation, the authors should consider a simple experiment in the stable cell line experiments (Figure 1) to test pulse frequency dependence of peak Na current. One would predict that PRRT2 expression will potentiate 'run down' of the channels, and this finding would be complementary to the biophysical data.</p>
<p>(3) The study of one K channel is limited, and the conclusion from these experiments represents an over-interpretation. I suggest removing these data unless many more K channels (ideally with measurable proxies for slow inactivation) were tested. These data do not contribute much to the story.</p>
<p>(4) In Figure 2, the authors should confirm that protein is indeed expressed in cells expressing each truncated PRRT2 construct. Absent expression should be ruled out as an explanation for absent enhancement of slow inactivation.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109327.1.sa2</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>As a member of DspB subfamily, PRRT2 is primarily expressed in the nervous system and has been associated with various paroxysmal neurological disorders. Previous studies have shown that PRRT2 directly interacts with Nav1.2 and Nav1.6, modulating channel properties and neuronal excitability.</p>
<p>In this study, Lu et al. reported that PRRT2 is a physiological regulator of Nav channel slow inactivation, promoting the development of Nav slow inactivation and impeding the recovery from slow inactivation. This effect can be replicated by the C-terminal region (256-346) of PRRT2, and is highly conserved across species from zebrafish, mouse, to human PRRT2. TRARG1 and TMEM233, the other two DspB family members, showed similar effects on Nav1.2 slow inactivation. Co-IP data confirms the interaction between Nav channels and PRRT2. Prrt2-mutant mice, which lack PRRT2 expression, require lower stimulation thresholds for evoking after-discharges when compared to WT mice.</p>
<p>Strengths:</p>
<p>(1) This study is well designed, and data support the conclusion that PRRT2 is a potent regulator of slow inactivation of Nav channels.</p>
<p>(2) This study reveals similar effects on Nav1.2 slow inactivation by PRRT2, TMEM233, and TRARG1, indicating a common regulation of Nav channels by DspB family members (Supplemental Figure 2). A recent study has shown that TMEM233 is essential for ExTxA (a plant toxin)-mediated inhibition on fast inactivation of Nav channels; and PRRT2 and TRARG1 could replicate this effect (Jami S, et al. Nat Commun 2023). It is possible that all three DspB members regulate Nav channel properties through the same mechanism, and exploring molecules that target PRRT2/TRARG1/TMEM233 might be a novel strategy for developing new treatments of DspB-related neurological diseases.</p>
<p>Weaknesses:</p>
<p>(1) Previously, the authors have reported that PRRT2 reduces Nav1.2 current density and alters biophysical properties of both Nav1.2 and Nav1.6 channels, including enhanced steady-state inactivation, slower recovery, and stronger use-dependent inhibition (Lu B, et al. Cell Rep 2021, Fig 3 &amp; S5). All those changes are expected to alter neuronal excitability and should be discussed.</p>
<p>(2) In this study, the fast inactivation kinetics was examined by a single stimulus at 0 mV, which may not be sufficient for the conclusion. Inactivation kinetics at more voltage potentials should be added.</p>
<p>(3) It is a little surprising that there is no difference in Nav1.2 current density in axon-blebs between WT and Prrt2-mutant mice (Figure 7B). PRRT2 significantly shifts steady-state slow inactivation curve to hyperpolarizing direction, at -70 mV, nearly 70% of Nav1.2 channels are inactivated by slow inactivation in cells expressing PRRT2 when compared to less than 10% in cells expressing GFP (Figure supplement 1B); with a holding potential of -70 mV, I would expect that most of Nav channels are inactivated in axon-blebs from WT mice but not in axon-blebs from Prrt2-mutant mice, and therefore sodium current density should be different in Figure 7B, which was not. Any explanation?</p>
<p>(3) Besides Nav channels, PRRT2 has been shown to act on Cav2.1 channels as well as molecules involved in neurotransmitter release, which may also contribute to abnormal neuronal activity in Prrt2-mutant mice. These should be mentioned when discussing PRRT2's role in neuronal resilience.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109327.1.sa1</article-id>
<title-group>
<article-title>Reviewer #3 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>This paper reveals that the neuronal protein PRRT2, previously known for its association with paroxysmal dyskinesia and infantile seizures, modulates the slow inactivation of voltage-gated sodium ion (Nav) channels, a gating process that limits excitability during prolonged activity. Using electrophysiology, molecular biology, and mouse models, the authors show that PRRT2 accelerates entry of Nav channels into the slow-inactivated state and slows their recovery, effectively dampening excessive excitability. The effect seems evolutionarily conserved, requires the C-terminal region of PRRT2, and is recapitulated in cortical neurons, where PRRT2 deficiency leads to hyper-responsiveness and reduced cortical resilience in vivo. These findings extend the functional repertoire of PRRT2, identifying it as a physiological brake on neuronal excitability. The work provides a mechanistic link between PRRT2 mutations and episodic neurological phenotypes.</p>
<p>Comments:</p>
<p>(1) The precise structural interface and the molecular basis of gating modulation remain inferred rather than demonstrated.</p>
<p>(2) The in vivo phenotype reflects a complex circuit outcome and does not isolate slow-inactivation defects per se.</p>
<p>(3) Expression of PRRT2 in muscle or heart is low, so the cross isoform claims are likely of limited physiological significance.</p>
<p>(4) The mechanistic separation between the trafficking of PRRT2 and its gating effects is not clearly resolved.</p>
<p>(5) Additional studies with Nav1.6 should be carried out.</p>
</body>
</sub-article>
<sub-article id="sa4" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109327.1.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Bin</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1456-2517</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Qi-Wu</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jing</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Xue-Mei</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Jun-Yan</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Guang</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Ke-Xian</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhuang</surname>
<given-names>Ling</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yu-Xian</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiong</surname>
<given-names>Zhi-Qi</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7727-8412</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<disp-quote content-type="editor-comment">
<p><bold>Public Reviews:</bold></p>
<p><bold>Reviewer #1 (Public review):</bold></p>
<p>Summary:</p>
<p>The manuscript by Lu and colleagues demonstrates convincingly that PRRT2 interacts with brain voltage-gated sodium channels to enhance slow inactivation in vitro and in vivo. The work is interesting and rigorously conducted. The relevance to normal physiology and disease pathophysiology (e.g., PRRT2-related genetic neurodevelopmental disorders) seems high. Some simple additional experiments could elevate the impact and make the study more complete.</p>
<p>Strengths:</p>
<p>Experiments are conducted rigorously, including experimenter blinding and appropriate controls. Data presentation is excellent and logical. The paper is well written for a general scientific audience.</p>
<p>Weaknesses:</p>
<p>There are a few missing experiments and one place where data are over-interpreted.</p>
<p>(1) An in vitro study of Nav1.6 is conspicuously absent. In addition to being a major brain Na channel, Nav1.6 is predominant in cerebellar Purkinje neurons, which the authors note lack PRRT2 expression. They speculate that the absence of PRRT2 in these neurons facilitates the high firing rate. This hypothesis would be strengthened if PRRT2 also enhanced slow inactivation of Nav1.6. If a stable Nav1.6 cell were not available, then simple transient co-transfection experiments would suffice.</p>
</disp-quote>
<p>We thank the reviewer for this suggestion. In the revised manuscript, we will examine whether PRRT2 modulates slow inactivation of Nav1.6 channels using heterologous co-expression experiments.</p>
<disp-quote content-type="editor-comment">
<p>(2) To further demonstrate the physiological impact of enhanced slow inactivation, the authors should consider a simple experiment in the stable cell line experiments (Figure 1) to test pulse frequency dependence of peak Na current. One would predict that PRRT2 expression will potentiate 'run down' of the channels, and this finding would be complementary to the biophysical data.</p>
</disp-quote>
<p>We agree that examining pulse frequency-dependent changes in peak sodium current would provide a functional readout linking PRRT2-mediated enhancement of slow inactivation to use-dependent channel availability. In the revision, we will include a pulse-train protocol to quantify use-dependent attenuation (“run-down”) of peak sodium current across stimulation trains and will compare this adaptation between control and PRRT2-expressing conditions.</p>
<disp-quote content-type="editor-comment">
<p>(3) The study of one K channel is limited, and the conclusion from these experiments represents an over-interpretation. I suggest removing these data unless many more K channels (ideally with measurable proxies for slow inactivation) were tested. These data do not contribute much to the story.</p>
</disp-quote>
<p>We agree with the reviewer’s assessment. To avoid over-interpretation and to maintain focus on PRRT2-dependent regulation of Nav channel slow inactivation, we will remove potassium channel dataset and the associated conclusions from the revised manuscript.</p>
<disp-quote content-type="editor-comment">
<p>(4) In Figure 2, the authors should confirm that protein is indeed expressed in cells expressing each truncated PRRT2 construct. Absent expression should be ruled out as an explanation for the enhancement of slow inactivation.</p>
</disp-quote>
<p>We appreciate the reviewer’s concern regarding expression of the truncated PRRT2 constructs in the Nav1.2 stable cell line, particularly PRRT2(1-266), which shows little effect on slow inactivation of Nav1.2 channels. In the revision, we will include expression controls for each truncation construct in the Nav1.2-expressing cells to rule out lack of expression as an explanation for the observed functional differences.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public review):</bold></p>
<p>Summary:</p>
<p>As a member of DspB subfamily, PRRT2 is primarily expressed in the nervous system and has been associated with various paroxysmal neurological disorders. Previous studies have shown that PRRT2 directly interacts with Nav1.2 and Nav1.6, modulating channel properties and neuronal excitability.</p>
<p>In this study, Lu et al. reported that PRRT2 is a physiological regulator of Nav channel slow inactivation, promoting the development of Nav slow inactivation and impeding the recovery from slow inactivation. This effect can be replicated by the C-terminal region (256-346) of PRRT2, and is highly conserved across species from zebrafish, mouse, to human PRRT2. TRARG1 and TMEM233, the other two DspB family members, showed similar effects on Nav1.2 slow inactivation. Co-IP data confirms the interaction between Nav channels and PRRT2. Prrt2-mutant mice, which lack PRRT2 expression, require lower stimulation thresholds for evoking after-discharges when compared to WT mice.</p>
<p>Strengths:</p>
<p>(1) This study is well designed, and data support the conclusion that PRRT2 is a potent regulator of slow inactivation of Nav channels.</p>
<p>(2) This study reveals similar effects on Nav1.2 slow inactivation by PRRT2, TMEM233, and TRARG1, indicating a common regulation of Nav channels by DspB family members (Supplemental Figure 2). A recent study has shown that TMEM233 is essential for ExTxA (a plant toxin)-mediated inhibition on fast inactivation of Nav channels; and PRRT2 and TRARG1 could replicate this effect (Jami S, et al. Nat Commun 2023). It is possible that all three DspB members regulate Nav channel properties through the same mechanism, and exploring molecules that target PRRT2/TRARG1/TMEM233 might be a novel strategy for developing new treatments of DspB-related neurological diseases.</p>
<p>Weaknesses:</p>
<p>(1) Previously, the authors have reported that PRRT2 reduces Nav1.2 current density and alters biophysical properties of both Nav1.2 and Nav1.6 channels, including enhanced steady-state inactivation, slower recovery, and stronger use-dependent inhibition (Lu B, et al. Cell Rep 2021, Fig 3 &amp; S5). All those changes are expected to alter neuronal excitability and should be discussed.</p>
</disp-quote>
<p>We agree that PRRT2 has been reported to exert multiple effects on Nav channels which are all expected to influence neuronal excitability (Fruscione et al., 2018; Lu et al., 2021; Valente et al., 2023). In the revised manuscript, we will expand the Discussion to integrate these prior findings and to clarify how these PRRT2-dependent changes may interact with (and potentially converge on) modulation of slow inactivation to shape neuronal excitability.</p>
<disp-quote content-type="editor-comment">
<p>(2) In this study, the fast inactivation kinetics was examined by a single stimulus at 0 mV, which may not be sufficient for the conclusion. Inactivation kinetics at more voltage potentials should be added.</p>
</disp-quote>
<p>We thank the reviewer for this suggestion. In the revision, we will extend our analysis of Nav1.2 fast-inactivation kinetics across a range of test potentials (e.g., -20, -10, 0, +10 and +20 mV) in the presence and absence of PRRT2.</p>
<disp-quote content-type="editor-comment">
<p>(3) It is a little surprising that there is no difference in Nav1.2 current density in axon-blebs between WT and Prrt2-mutant mice (Figure 7B). PRRT2 significantly shifts steady-state slow inactivation curve to hyperpolarizing direction, at -70 mV, nearly 70% of Nav1.2 channels are inactivated by slow inactivation in cells expressing PRRT2 when compared to less than 10% in cells expressing GFP (Figure supplement 1B); with a holding potential of -70 mV, I would expect that most of Nav channels are inactivated in axon-blebs from WT mice but not in axon-blebs from Prrt2-mutant mice, and therefore sodium current density should be different in Figure 7B, which was not. Any explanation?</p>
</disp-quote>
<p>We appreciate the reviewer for raising this point. In our axonal bleb recordings, although the holding potential was -70 mV, sodium current density was measured after a hyperpolarizing pre-pulse (-110 mV) to relieve inactivation immediately prior to the test depolarization (as described in the Methods). Thus, the current density measurement in Figure 7B reflects the maximal available current following this recovery step, rather than the steady-state availability at -70 mV. In the revision, we will state this explicitly in the Results and/or figure legend to avoid confusion.</p>
<disp-quote content-type="editor-comment">
<p>(4) Besides Nav channels, PRRT2 has been shown to act on Cav2.1 channels as well as molecules involved in neurotransmitter release, which may also contribute to abnormal neuronal activity in Prrt2-mutant mice. These should be mentioned when discussing PRRT2's role in neuronal resilience.</p>
</disp-quote>
<p>We agree with the reviewer. In the revised manuscript, we will broaden the Discussion to acknowledge PRRT2 functions beyond Nav channels, including reported roles in Cav2.1 regulation and neurotransmitter release. We will frame the in vivo phenotypes in Prrt2-mutant mice as likely arising from convergent mechanisms—altered intrinsic excitability together with changes in synaptic transmission.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3 (Public review):</bold></p>
<p>This paper reveals that the neuronal protein PRRT2, previously known for its association with paroxysmal dyskinesia and infantile seizures, modulates the slow inactivation of voltage-gated sodium ion (Nav) channels, a gating process that limits excitability during prolonged activity. Using electrophysiology, molecular biology, and mouse models, the authors show that PRRT2 accelerates entry of Nav channels into the slow-inactivated state and slows their recovery, effectively dampening excessive excitability. The effect seems evolutionarily conserved, requires the C-terminal region of PRRT2, and is recapitulated in cortical neurons, where PRRT2 deficiency leads to hyper-responsiveness and reduced cortical resilience in vivo. These findings extend the functional repertoire of PRRT2, identifying it as a physiological brake on neuronal excitability. The work provides a mechanistic link between PRRT2 mutations and episodic neurological phenotypes.</p>
<p>Comments:</p>
<p>(1) The precise structural interface and the molecular basis of gating modulation remain inferred rather than demonstrated.</p>
</disp-quote>
<p>We thank the reviewer for this comment. In the revision, we will make it explicit that our structural modeling are based on prediction rather than evidential. We will also expand the Limitations section to highlight that direct structural and biochemical mapping of the PRRT2-Nav interface (e.g., through targeted mutagenesis, crosslinking, and/or structural determination) will be required to define the binding interface and establish the molecular basis of gating modulation.</p>
<disp-quote content-type="editor-comment">
<p>(2) The in vivo phenotype reflects a complex circuit outcome and does not isolate slow-inactivation defects per se.</p>
</disp-quote>
<p>We agree with the reviewer. In the revision, we will refine the Discussion to avoid over-attributing the in vivo phenotype to slow-inactivation defects alone and to explicitly state that impaired slow inactivation in Prrt2-mutant mice represents one plausible contributing mechanism to reduced cortical resilience, alongside other PRRT2-dependent process.</p>
<disp-quote content-type="editor-comment">
<p>(3) Expression of PRRT2 in muscle or heart is low, so the cross-isoform claims are likely of limited physiological significance.</p>
</disp-quote>
<p>We thank the review for your comment about physiological relevance. In the revised manuscript, we will clarify that our Nav isoform panel was designed to assess mechanistic generality at the channel level rather than to imply broad in vivo relevance across tissues. We will also expand the Discussion to emphasize that any therapeutic strategy involving PRRT2 delivery should consider its consistent effect on slow inactivation across multiple Nav isoforms.</p>
<disp-quote content-type="editor-comment">
<p>(4) The mechanistic separation between the trafficking effect of PRRT2 and its gating effects is not clearly resolved.</p>
</disp-quote>
<p>We appreciate the reviewer for raising this important point. In the revision, we will expand the Discussion to clarify why we interpret the effect of PRRT2 on slow inactivation as a gating modulation rather than a secondary consequence of altered channel abundance or localization. First, our slow inactivation measurements are expressed as the fraction of available channels after depolarization conditioning relative to baseline availability within the same cell (post-/pre-conditioning), which minimizes confounding by differences in initial surface expression. Second, the slow inactivation of Nav channel occurs on a rapid, activity-dependent timescale (seconds), whereas remarkable changes in trafficking and surface abundance generally develop over longer intervals (minutes to hours).</p>
<disp-quote content-type="editor-comment">
<p>(5) Additional studies with Nav1.6 should be carried out.</p>
</disp-quote>
<p>We thank the reviewer’s suggestion. We will include Nav1.6 slow inactivation experiments in the revised manuscript.</p>
</body>
</sub-article>
</article>